Chair
Pharmacotherapy
Date of appointment 12.07.2001
Inaugural lecture date 07.11.2002
Profile

Anthonius de Boer is Professor of Pharmacotherapy from 2001.

With great pleasure he combines educational and research activities within the department of Pharmaceutical Sciences. In line with his background (MD, PhD, epidemiologist B and clinical pharmacologist) he has a great and broad interest in drug effects and drug research from the development of drugs in phase 1 studies up to and including pharmacoepidemiological research after marketing of drugs. 

From the first of august 2017 he is also the Chairman of the Dutch Medicines Evaluation Board and member of several editorial, research and societal committees (see Additional functions)

 

Involved in the following study programme(s)

Interview about the Propatria study
Gegenereerd op 2017-10-18 06:05:09
Curriculum vitae

Prof. Anthonius de Boer, MD, PhD was trained for three years in Internal Medicine followed by a PhD research period in clinical pharmacology. After his PhD graduation in 1990 he was appointed as assistant professor in Clinical Epidemiology followed by an associate professorship of pharmacotherapy. In 1994 he was registered as Epidemiologist and in 1996 as Clinical Pharmacologist. He was appointed in 2001 as professor of pharmacotherapy and director of the Pharmacy School. From 2007 until September 2015 he was the head of the Department of Pharmaceutical Sciences, Utrecht University. From the first of August 2017 he is also the chair of the Netherlands Medicines Evaluation Board.

Gegenereerd op 2017-10-18 06:05:09
All publications
  2017 - Scholarly publications
van Brummelen, Emilie M J, de Boer, Anthonius, Beijnen, Jos H & Schellens, Jan H M (02.06.2017). BRAF Mutations as Predictive Biomarker for Response to Anti-EGFR Monoclonal Antibodies. Oncologist © AlphaMed Press 2017..
Bezin, Julien, Groenwold, Rolf, Ali, M Sanni, Lassalle, Régis, Robinson, Philip, de Boer, Anthonius, Moore, Nicholas, Klungel, Olaf H & Pariente, Antoine (03.03.2017). Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome. Pharmacoepidemiology and Drug Safety, 26 (3), (pp. 285-293) (9 p.). Copyright © 2017 John Wiley & Sons, Ltd..
Althunian, Turki A, de Boer, Anthonius, Groenwold, Rolf H H & Klungel, Olaf H (06.04.2017). Defining the non-inferiority margin and analyzing non-inferiority - An overview. British Journal of Clinical Pharmacology This article is protected by copyright. All rights reserved..
Baranova, Ekaterina V, Verhoef, Talitha, Ragia, Georgia, Cessie, Saskia Le, Asselbergs, Folkert W, de Boer, Anthonius, Manolopoulos, Vangelis G, Maitland-van der Zee, Anke H & , (07.01.2017). Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes. Journal of Thrombosis and Haemostasis, 15 (3), (pp. 465-472) (8 p.). This article is protected by copyright. All rights reserved..
Ahmadizar, Fariba, Vijverberg, Susanne J H, Arets, Hubertus G M, de Boer, Anthonius, Turner, Steve, Devereux, Graham, Arabkhazaeli, Ali, Soares, Patricia, Mukhopadhyay, Somnath, Garssen, Johan, Palmer, Colin N A, de Jongste, Johan C, Jaddoe, Vincent Wv, Duijts, Liesbeth, van Meel, Evelien R, Kraneveld, Aletta D & Maitland-van der Zee, Anke H (08.06.2017). Early life antibiotic use and the risk of asthma and asthma exacerbations in children. Pediatric Allergy and Immunology This article is protected by copyright. All rights reserved..
Bakhriansyah, Mohammad, Souverein, Patrick C, de Boer, Anthonius & Klungel, Olaf H (31.03.2017). Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors - a case-control study. Pharmacoepidemiology and Drug Safety © 2017 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd..
Mahmoudpour, Seyed H., Veluchamy, Abirami, Siddiqui, Moneeza K., Asselbergs, Folkert W., Souverein, Patrick C., De Keyser, Catherine E., Hofman, Albert, Lang, Chim C., Doney, Alexander S.F., Stricker, Bruno H., De Boer, Anthonius, Maitland-Van Der Zee, Anke H. & Palmer, Colin N.A. (01.04.2017). Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenetics and Genomics, 27 (3), (pp. 112-119) (8 p.).
Althunian, Turki A, de Boer, Anthonius, Klungel, Olaf H, Insani, Widya N & Groenwold, Rolf H H (2017). Methods of defining the non-inferiority margin in randomized, double-blind controlled trials - a systematic review. Trials, 18 (1), (pp. 107).
Makady, Amr, Ham, Renske Ten, de Boer, Anthonius, Hillege, Hans, Klungel, Olaf, Goettsch, Wim & , (2017). Policies for Use of Real-World Data in Health Technology Assessment (HTA) - A Comparative Study of Six HTA Agencies. Value in Health, 20 (4), (pp. 520-532) (13 p.). Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved..
Meulendijks, Didier, Henricks, Linda M, Jacobs, Bart A W, Aliev, Abidin, Deenen, Maarten J, de Vries, Niels, Rosing, Hilde, van Werkhoven, Erik, de Boer, Anthonius, Beijnen, Jos H, Mandigers, Caroline M P W, Soesan, Marcel, Cats, Annemieke & Schellens, Jan H M (20.04.2017). Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity. British Journal of Cancer, 116, (pp. 1415–1424).
Fazeli Farsani, S., Abdullah-Koolmees, Heshu, Souverein, Patrick C, de Boer, Anthonius & Mantel-Teeuwisse, Aukje K (24.04.2017). Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents - A population-based cohort study. Pediatric Diabetes © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Alharbi, F F, Souverein, P C, de Groot, M C, Maitland-van der Zee, A H, de Boer, A & Klungel, O H (2017). Risk of acute myocardial infarction after discontinuation of antihypertensive agents - a case-control study. Journal of Human Hypertension
Gieling, Emilie, van den Ham, Hendrika A, van Onzenoort, Hein, Bos, Jacqueline, Kramers, Cornelis, de Boer, Anthonius, de Vries, Frank & Burden, Andrea M (16.02.2017). Risk of major bleeding and stroke associated with the use of VKAs, NOACs and aspirin in patients with atrial fibrillation - a cohort study. British Journal of Clinical Pharmacology This article is protected by copyright. All rights reserved..
Stolk, Leo M, de Vries, Frank, Ebbelaar, Chiel, de Boer, Anthonius, Schalekamp, Tom, Souverein, Patrick, Ten Cate-Hoek, Arina & Burden, Andrea M (2017). Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. British Journal of Clinical Pharmacology © 2017 The British Pharmacological Society..
Kleijnen, Sarah, Meneses Leonardo Alves, Teresa, Meijboom, Kim, Lipska, Iga, De Boer, Anthonius, Leufkens, Hubertus G & Goettsch, Wim G (11.04.2017). The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries. Quality of Life Research
Alharbi, Fawaz F, Souverein, Patrick C, de Groot, Mark C H, Blom, Marieke T, de Boer, Anthonius, Klungel, Olaf H & Tan, Hanno L (29.06.2017). The Impact of Serum Potassium-Influencing Antihypertensive Drugs on the Risk of Out-of-Hospital Cardiac Arrest - A Case Control Study. British Journal of Clinical Pharmacology This article is protected by copyright. All rights reserved..
Bronsveld, Heleen K, Peeters, Paul J H L, de Groot, Mark C H, de Boer, Anthonius, Schmidt, Marjanka K & De Bruin, Marie L (23.02.2017). Trends in breast cancer incidence among women with type-2 diabetes in British general practice. Primary Care Diabetes Copyright © 2017 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved..
Makady, Amr, de Boer, Anthonius, Hillege, Hans, Klungel, Olaf & Goettsch, Wim (2017). What Is Real-World Data (RWD)? A Review of Definitions Based on Literature and Stakeholder Interviews. Value in Health, (pp. 502) (1 p.).
  2016 - Scholarly publications
Leusink, Maarten, Leusink, Maarten, Maitland-Van Der Zee, Anke H., Ding, Bo, Drenos, Fotios, Drenos, Fotios, Van Iperen, Erik P A, Van Iperen, Erik P A, Warren, Helen R., Warren, Helen R., Caulfield, Mark J., Caulfield, Mark J., Cupples, L. Adrienne, Cupples, L. Adrienne, Cushman, Mary, Hingorani, Aroon D., Hoogeveen, Ron C., Hovingh, G. Kees, Kumari, Meena, Lange, Leslie A., Munroe, Patricia B., Munroe, Patricia B., Nyberg, Fredrik, Nyberg, Fredrik, Schreiner, Pamela J., Sivapalaratnam, Suthesh, De Bakker, Paul I W, De Bakker, Paul I W, De Boer, Anthonius, Keating, Brendan J., Asselbergs, Folkert W., Asselbergs, Folkert W., Asselbergs, Folkert W. & Onland-Moret, N. Charlotte (01.04.2016). A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering. Pharmacogenomics, 17 (6), (pp. 583-591) (9 p.).
Alharbi, Fawaz F., Kholod, Anzhelika A.V., Souverein, Patrick C., Meyboom, Ronald H., de Groot, Mark, De Boer, Anthonius & Klungel, Olaf H. (2016). A novel approach to study the impact of ethnicity on reporting of cough/angioedema with RAS inhibitors in VigiBase. Pharmacoepidemiology and Drug Safety, 25 (S3), (pp. 443-44) (2 p.).
Zhang, Yumao, de Boer, Anthonius, Verhoef, Talitha I, van der Meer, Felix Jm, Le Cessie, Saskia, Manolopoulos, Vangelis G, Maitland-van der Zee, Anke H & , (19.12.2016). Age-stratified outcome of genotype-guided dosing algorithm for acenocoumarol and phenprocoumon. Journal of Thrombosis and Haemostasis This article is protected by copyright. All rights reserved..
Ahmadizar, Fariba, Souverein, Patrick C., Arets, Hubertus G M, de Boer, Anthonius & Maitland-van der Zee, Anke H. (01.01.2016). Asthma related medication use and exacerbations in children and adolescents with type 1 diabetes. Pediatric Pulmonology
Ahmadizar, Fariba, Fazeli Farsani, Soulmaz, Souverein, Patrick C, van der Vorst, Marja Mj, de Boer, Anthonius & Maitland-van der Zee, Anke H (04.08.2016). Cardiovascular medication use and cardiovascular disease in children and adolescents with type 1 diabetes - a population-based cohort study. Pediatric Diabetes, 17 (6), (pp. 433–440). © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
De Groot, Mark C. H., Candore, Gianmario, Uddin, Jamal, Souverein, Patrick, Ali, M. Sanni, Belitser, S., Huerta, Consuelo, Groenwold, Rolf H. H., Alvarez, Yolanda, Slattery, Jim, Korevaar, Joke, Hoes, Arno W., Roes, Kit C. B., de Boer, Anthonius, Douglas, Ian J., Schlienger, Raymond G., Reynolds, Robert, Klungel, Olaf H. & Gardarsdottir, Helga (01.03.2016). Case-only designs for studying the association of antidepressants and hip or femur fracture. Pharmacoepidemiology and Drug Safety, 25 (Supplement S1), (pp. 103-113) (11 p.).
Ahmadizar, Fariba, Vijverberg, Susanne J H, Arets, Hubertus G M, de Boer, Anthonius, Lang, Jason E, Kattan, Meyer, Palmer, Colin N A, Mukhopadhyay, Somnath, Turner, Steve & Maitland-van der Zee, Anke H (01.09.2016). Childhood obesity in relation to poor asthma control and exacerbation - a meta-analysis. European Respiratory Journal Copyright ©ERS 2016..
Mahmoud Pour, Seyed Hamidreza, Baranova, E V, Souverein, P C, Asselbergs, F W, de Boer, A, Maitland-van der Zee, A H & , (15.08.2016). Determinants of angiotensin converting enzyme-inhibitor (ACEI) intolerance and angioedema in the UK clinical practice research datalink. British Journal of Clinical Pharmacology This article is protected by copyright. All rights reserved..
Ahmadizar, F., Vijverberg, S., Arets, H., de Boer, Anthonius, Garssen, J., Kraneveld, A.D. & Maitland-Van Der Zee, A.-H. (01.08.2016). Early life antibiotic exposure is associated with an increased risk of atopic eczema and hay fever. Allergy: European Journal of Allergy and Clinical Immunology, 71, (pp. 319) (1 p.).
De Boer, Anthonius, Cohen, Adam F., Ferro, Albert, Flockhart, Dave A., Gilchrist, Annette, Isbister, Geoff, Loke, Yoon K., Ross, Sarah, Somogyi, Andrew A. & Webb, Andrew J. (01.01.2016). Editors' report for 2015, December 2015. British Journal of Clinical Pharmacology, 81 (1), (pp. 6-7) (2 p.).
Uddin, Md Jamal, Groenwold, Rolf H H, de Boer, Anthonius, Afonso, Ana S M, Primatesta, Paola, Becker, Claudia, Belitser, S., Hoes, Arno W., Roes, Kit C B & Klungel, Olaf H. (01.03.2016). Evaluating different physician's prescribing preference based instrumental variables in two primary care databases - A study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction. Pharmacoepidemiology and Drug Safety, 25 (Supplement 1), (pp. 132-141) (10 p.).
Tjin A Tsoi, Sharon L N M, de Boer, Anthonius, Croiset, Gerda, Koster, Andries S & Kusurkar, Rashmi A (2016). Factors Influencing Participation in Continuing Professional Development - A Focus on Motivation Among Pharmacists. Journal of Continuing Education in the Health Professions, 36 (3), (pp. 144-150) (7 p.).
Leusink, M., Vijverberg, S.J.H., Koenderman, L., Raaijmakers, J.A.M., de Jongste, J.C., Sterk, P.J., Duiverman, E.J., Onland-Moret, N.C., Postma, D.S., de Boer, Anthonius, de Bakker, P.I.W., Koppelman, G.H. & Maitland-van der Zee, A.H. (2016). Genetic variation in uncontrolled childhood asthma despite ICS treatment. Pharmacogenomics Journal, 16, (pp. 158–163).
Verhaegh, B P M, de Vries, F, Masclee, A A M, Keshavarzian, A, de Boer, A, Souverein, P C, Pierik, M J & Jonkers, D M A E (2016). High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Alimentary Pharmacology and Therapeutics, 43 (9), (pp. 1004-1013). © 2016 John Wiley & Sons Ltd..
Fazeli Farsani, Soulmaz, Souverein, Patrick C, van der Vorst, Marja M J, Knibbe, Catherijne A J, Herings, Ron M C, de Boer, Anthonius & Mantel-Teeuwisse, Aukje K (05.01.2016). Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands. Pediatric Diabetes, 17 (1), (pp. 44–52). © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Boef, Anna G C, Souverein, Patrick C, Vandenbroucke, Jan P, van Hylckama Vlieg, Astrid, de Boer, Anthonius, le Cessie, Saskia & Dekkers, Olaf M (08.01.2016). Instrumental variable analysis as a complementary analysis in studies of adverse effects - venous thromboembolism and second-generation versus third-generation oral contraceptives. Pharmacoepidemiology and Drug Safety, 25 (3), (pp. 317-324) (8 p.). Copyright © 2016 John Wiley & Sons, Ltd..
Uddin, Md Jamal, Groenwold, Rolf H H, de Boer, Anthonius, Gardarsdottir, Helga, Martin, Elisa, Candore, Gianmario, Belitser, Svetlana V., Hoes, Arno W., Roes, Kit C B & Klungel, Olaf H. (01.03.2016). Instrumental variables analysis using multiple databases - An example of antidepressant use and risk of hip fracture. Pharmacoepidemiology and Drug Safety, 25 (Supplement S1), (pp. 122-131) (10 p.).
Mahmoud Pour, Seyed Hamidreza, Siddiqui, Moneeza K., Veluchamy, Abirami, Asselbergs, Folkert W., Souverein, Patrick C., De Keyser, Catherine E., Hofman, Albert, Stricker, Bruno H., De Boer, Anthonius, Maitland-Van Der Zee, Anke-Hilse & Palmer, Colin N.A. (01.08.2016). Meta-analysis of the Genome Wide Association Studies (GWAS) on the intolerance of Angiotensin Converting Enzyme Inhibitors (ACEIs). Pharmacoepidemiology and Drug Safety, 25, (pp. 383) (1 p.).
Ali, M Sanni, Groenwold, Rolf H H, Belitser, S., Souverein, Patrick C, Martín, Elisa, Gatto, Nicolle M, Huerta, Consuelo, Gardarsdottir, Helga, Roes, Kit C B, Hoes, Arno W, de Boer, Anthonius & Klungel, Olaf H (2016). Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods - the example of antidepressant use and the risk of hip fracture. Pharmacoepidemiology and Drug Safety, 25 (Suppl 1), (pp. 114-121) (8 p.). Copyright © 2016 John Wiley & Sons, Ltd..
Althunian, Turki A.I., De Boer, Anthonius, Klungel, Olaf H., Insani, Widya N. & Groenwold, Rolf H.H. (01.08.2016). Methods of defining the noninferiority margin: A systematic review. Pharmacoepidemiology and Drug Safety, 25, (pp. 139-140) (2 p.).
Uddin, Md Jamal, Groenwold, Rolf H H, Ali, Mohammed Sanni, de Boer, Anthonius, Roes, Kit C B, Chowdhury, Muhammad A B & Klungel, Olaf H. (18.04.2016). Methods to control for unmeasured confounding in pharmacoepidemiology - an overview. International Journal of Clinical Pharmacy, 38 (3), (pp. 714-723) (10 p.).
Klungel, Olaf H., Kurz, Xavier, de Groot, Mark C. H., Schlienger, Raymond G., Tcherny-Lessenot, Stephanie, Grimaldi, Lamiae, Ibáñez, Luisa, Groenwold, Rolf H. H., Reynolds, Robert F., Alvarez, Y., Candore, G., Durand, J., Slattery, J., Hasford, J., Rottenkolber, M., Schmiedl, S., de Abajo Iglesias, F., Gil, M., Gonzalez, R., Huerta Alvarez, C., Martin, E., Oliva, B., Requena, G., Amelio, J., Brauer, R., Downey, G., Feudjo-Tepie, M., Schoonen, M., Johansson, S., Robinson, J., Schuerch, M., Tatt, I., Petri, H., Garcia, L.A., Ruigomez, A., Campbell, J., Gallagher, A., Ng, E., van Staa, T.P., Demol, O., Boudiaf, N., Davis, K., Logie, J., Pimenta, J., Beau-Lejdstrom, R., Grimaldi-Bensouda, L., Abenhaim, L., Grimaldi-Bensouda, L., Rossignol, M., Hesse, U., Rønn, P.F., Miret, M., Fortuny, J., Primatesta, P., Rivero, E., Schlienger, R., Bate, A., Gatto, N., Ballarin, E., Ferrer, P., Ibañez, L., Laporte, J.R., Sabaté, M., Abbing-Karahagopian, V., Ali, S., de Bakker, D., Belitser, S., de Boer, Anthonius, De Bruin, M.L., Egberts, A.C.G., van Dijk, L., Gardarsdottir, H., Hoes, A.W., Leufkens, H.G.M., Pestman, W., Roes, K.C.B., Souverein, P., Rutten, F., Uddin, J., van den Ham, H.A., Voogd, E., de Vries, Frank, De Bruin, M.L., Udo, R., Auclert, L., Juhaeri, J., Mazuranok, L., Wise, L., Irvine, D., Dolin, P., Gasse, C. & , (01.03.2016). Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project. Pharmacoepidemiology and Drug Safety, 25 (supplement S1), (pp. 156-165) (10 p.).
Yasmina, Alfi, de Boer, Anthonius, Deneer, Vera H M, Souverein, Patrick C & Klungel, Olaf H (23.09.2016). Patterns of antiplatelet drug use after a first myocardial infarction during a 10-years period. British Journal of Clinical Pharmacology This article is protected by copyright. All rights reserved..
Maagdenberg, Hedy, Vijverberg, Susanne J. H., Bierings, Marc B., Carleton, Bruce C., Arets, Hubertus G. M., de Boer, Anthonius & Maitland-van der Zee, Anke H. (03.05.2016). Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine. Paediatric Drugs, (pp. 1-10) (10 p.).
Kleijnen, S, Lipska, I, Leonardo Alves, T, Meijboom, K, Elsada, A, Vervölgyi, V, d'Andon, A, Timoney, A, Leufkens, H G, De Boer, A & Goettsch, W G (20.06.2016). Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries. Annals of Oncology (8 p.). © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com..
Meulendijks, Didier, Henricks, Linda M, Amstutz, Ursula, Froehlich, Tanja K, Largiadèr, Carlo R, Beijnen, Jos H, de Boer, Anthonius, Deenen, Maarten J, Cats, Annemieke & Schellens, Jan H M (25.01.2016). Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity. International Journal of Cancer, 138 (11), (pp. 2752-2761). © 2016 UICC..
Leusink, Maarten, Onland-Moret, N. Charlotte, De Bakker, Paul I W, De Boer, Anthonius & Maitland-Van Der Zee, Anke H. (01.01.2016). Seventeen years of statin pharmacogenetics - A systematic review. Pharmacogenomics, 17 (2), (pp. 163-180) (18 p.).
Nielen, Johannes T H, Emans, Pieter J, Dagnelie, Pieter C, Boonen, Annelies, Lalmohamed, Arief, de Boer, Anthonius, van den Bemt, Bart J F & de Vries, Frank (2016). Severity of Diabetes Mellitus and Total Hip or Knee Replacement - A Population-Based Case-Control Study. Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 95 (20).
Lalmohamed, Arief, van Staa, Tjeerd P, Vestergaard, Peter, Leufkens, Hubertus G M, de Boer, Anthonius, Emans, Pieter, Cooper, Cyrus & de Vries, Frank (01.07.2016). Statins and Risk of Lower Limb Revision Surgery - The Influence of Differences in Study Design Using Electronic Health Records From the United Kingdom and Denmark. American Journal of Epidemiology, 184 (1), (pp. 58-66) (9 p.). © The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com..
Schmidt, A. F., Klungel, O. H., Nielen, M., de Boer, A., Groenwold, R. H H & Hoes, A. W. (15.02.2016). Tailoring treatments using treatment effect modification. Pharmacoepidemiology and Drug Safety, 25 (4), (pp. 355-362) (8 p.).
van der Aa, Marloes P, Hoving, Vera, van de Garde, Ewoudt M W, de Boer, Anthonius, Knibbe, Catherijne A J & van der Vorst, Marja M J (2016). The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents - Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial. Journal of Obesity, 2016 (7 p.).
Alharbi, Fawaz F., Kholod, Anzhelika A.V., Souverein, Patrick C., Meyboom, Ron H., de Groot, Mark, De Boer, Anthonius & Klungel, Olaf H. (01.08.2016). The impact of age and gender on reporting of cough and angioedema with RAS inhibitors: A case/non-case in VigiBase. Pharmacoepidemiology and Drug Safety, 25, (pp. 442) (1 p.).
Tjin A Tsoi, Sharon L N M, de Boer, Anthonius, Croiset, Gerda, Koster, Andries S & Kusurkar, Rashmi A (2016). Unraveling Motivational Profiles of Health Care Professionals for Continuing Education - The Example of Pharmacists in the Netherlands. Journal of Continuing Education in the Health Professions, 36 (1), (pp. 46-54) (9 p.).
Nielen, Johannes T H, de Vries, Frank, Dagnelie, Pieter C, van den Bemt, Bartholomeus J F, Emans, Pieter J, Lalmohamed, Arief, de Boer, Anthonius & Boonen, Annelies E R C H (08.02.2016). Use of thiazolidinediones and the risk of elective hip or knee replacement - a population based case-control study. British Journal of Clinical Pharmacology, 81 (2), (pp. 370–378). This article is protected by copyright. All rights reserved..
Schmidt, A F, Groenwold, R H H, Amsellem, P, Bacon, N, Klungel, O H, Hoes, A W, de Boer, Anthonius, Kow, K, Maritato, K, Kirpensteijn, J & Nielen, M (01.03.2016). Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis. Preventive Veterinary Medicine, 125, (pp. 116–125) (10 p.). Copyright © 2015 Elsevier B.V. All rights reserved..
  2015 - Scholarly publications
Franken, Margreet, Stolk, Elly, Scharringhausen, Tessa, de Boer, Anthonius & Koopmanschap, Marc (2015). A comparative study of the role of disease severity in drug reimbursement decision making in four European countries. Health Policy, 119 (2), (pp. 195–202) (8 p.). Copyright © 2014 Elsevier Ireland Ltd. All rights reserved..
Mahmoud Pour, Seyed Hamidreza, Asselbergs, F.W., Souverein, Patrick, de Boer, Anthonius & Maitland - van der Zee, Anke-Hilse (01.11.2015). Angiotensin converting enzyme inhibitors prescribing pattern for different indications: A population based study. Value in Health, 18 (7), (pp. 402) (1 p.).
Uddin, Jamal, Groenwold, Rolf H.H., Ali, M. Sanni, Candore, Gianmario, De Groot, Mark C.H., Souverein, Patrick C., Alvarez, Yolanda, Belitser, S., Hoes, Arno W., De Boer, Anthonius, Roes, Kit C.B., Klungel, Olaf H. & Gardarsdottir, Helga (01.08.2015). Application of the self-controlled case series design in pharmacoepidemiological studies: A cautionary note. European Journal of Epidemiology, 30 (8), (pp. 903) (1 p.).
Warnier, Miriam Jacoba, Rutten, Frans Hendrik, Souverein, Patrick Cyriel, de Boer, Anthonius, Hoes, Arno Wilhelmus & De Bruin, Marie Louise (2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiology and Drug Safety, 24 (7), (pp. 701-8) (8 p.). Copyright © 2015 John Wiley & Sons, Ltd..
Veldhuis-Vlug, A G, Oei, L, Souverein, P C, Tanck, M W T, Rivadeneira, F, Zillikens, M C, Kamphuisen, P W, Maitland-van der Zee, A H, de Groot, M C H, Hofman, A, Uitterlinden, A G, Fliers, E, de Boer, A & Bisschop, P H (25.04.2015). Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density. Osteoporosis International, 26 (7), (pp. 2019-2027).
Ahmadizar, Fariba, Maitland-Van Der Zee, Anke-Hilse, De Boer, Anthonius, Souverein, Patrick & Arets, Hubertus (01.09.2015). Asthma medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study. Pharmacoepidemiology and Drug Safety, 24 (S1), (pp. 275) (1 p.).
Kleijnen, Sarah, Fathallah, Mohammed, van der Linden, Michiel W, Vancraeynest, Piet, Dahmani, Bachir, Timoney, Angela, De Boer, Anthonius, Leufkens, Hubertus G & Goettsch, Wim G (2015). Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments. Value in Health, 18 (5), (pp. 663-72) (10 p.). Copyright © 2015. Published by Elsevier Inc..
Mahmoud Pour, S.H., Asselbergs, Folkert W, de Keyser, Catherine E, Souverein, P.C., Hofman, A., Stricker, Bruno H Ch, de Boer, A. & van der Zee, A.H. (2015). Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors. International Journal of Clinical Pharmacy
Fazelifarsani, Soulmaz, Souverein, Patrick C, van der Vorst, Marja M J, Knibbe, Catherijne A J, de Boer, Anthonius & Mantel-Teeuwisse, Aukje K (2015). Chronic comorbidities in children with type 1 diabetes - a population-based cohort study. Archives of Disease in Childhood, 100 (8), (pp. 763-8) (6 p.). Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions..
Zhang, Yumao, De Boer, Anthonius, Verhoef, Talitha I., Van Der Meer, Felix J.M., Le Cessie, Saskia, Maitland-Van Der Zee, Anke H., Barallon, Rita, Daly, Ann, Maitland-Van Der Zee, Anke-Hilse, Redekop, Ken, Stingl, Julia, Manolopoulos, Vangelis G., Rosendaal, Frits R. & Wadelius, Mia (01.07.2015). Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands. Thrombosis Research, 136 (1), (pp. 94-100) (7 p.).
Ahmadizar, Fariba, Onland-Moret, N Charlotte, de Boer, Anthonius, Liu, Geoffrey & Maitland-van der Zee, Anke H (2015). Correction - Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One, 10 (10), (pp. e0141704).
Ali, Sanni, Groenwold, Rolf H.H., Belitser, S., Roes, Kit C.B., Hoes, Arno W., De Boer, Anthonius & Klungel, Olaf H. (01.09.2015). Covariate balance assessment, model selection and bias in propensity score matching: A simulation study. Pharmacoepidemiology and Drug Safety, 24, (pp. 22) (1 p.).
Verhoef, Talitha I, Redekop, William K, de Boer, Anthonius, Maitland-van der Zee, Anke Hilse & , (2015). Economic evaluation of a pharmacogenetic dosing algorithm for coumarin anticoagulants in The Netherlands. Pharmacogenomics, 16 (2), (pp. 101-14) (14 p.).
Ahmadizar, Fariba, Onland-Moret, N. Charlotte, De Boer, Anthonius, Liu, Geoffrey & Maitland-Van Der Zee, Anke H. (02.09.2015). Efficacy and safety assessment of the addition of bevacizumab to adjuvant therapy agents in cancer patients: A systematic review and meta-analysis of randomized controlled trials. PLoS One, 10 (9).
Bazargani, Y T, de Boer, Anthonius, Schellens, J H M, Leufkens, H G M & Mantel-Teeuwisse, Aukje K (2015). Essential medicines for breast cancer in low and middle income countries. BMC Cancer, 15 (591).
Uddin, Md. Jamal, Groenwold, Rolf H.H., Ali, Mohammed Sanni, Candore, Gianmario, De Groot, Mark C.H., Souverein, Patrick C., Alvarez, Yolanda, Belitser, S., Hoes, Arno W., De Boer, Anthonius, Roes, Kit C.B., Klungel, Olaf & Gardarsdottir, Helga (01.09.2015). Impact of violations of the assumptions of the self-controlled case series design in pharmacoepidemiological studies: An example of antidepressants use and the risk of hip fracture. Pharmacoepidemiology and Drug Safety, 24, (pp. 2-3) (2 p.).
Blom, M. T., Jansen, S., de Jonghe, A., van Munster, B. C., de Boer, Anthonius, de Rooij, S. E., Tan, H. L. & van der Velde, Nathalie (01.05.2015). In-hospital haloperidol use and perioperative changes in QTc-duration. Journal of Nutrition, Health and Aging, 19 (5), (pp. 583-589) (7 p.).
Bronsveld, Heleen K., Ter Braak, Bas, Karlstad, Øystein, Vestergaard, Peter, Starup-Linde, Jakob, Bazelier, Marloes T., de Bruin, Marieke, De Boer, Anthonius, Siezen, Christine L.E., Van De Water, Bob, Van Der Laan, Jan Willem & Schmidt, Marjanka K. (01.09.2015). Insulin treatment and breast cancer risk; A systematic review of in vitro, animal and epidemiological evidence. Pharmacoepidemiology and Drug Safety, 24, (pp. 51-52) (2 p.).
Hazelbag, Christijan M, Klungel, Olaf H, van Staa, Tjeerd P, de Boer, Anthonius & Groenwold, Rolf H H (2015). Left truncation results in substantial bias of the relation between time-dependent exposures and adverse events. International Journal of Epidemiology, 25 (8), (pp. 590-6) (7 p.). Copyright © 2015 Elsevier Inc. All rights reserved..
Fazeli Farsani, S, Souverein, P C, Overbeek, J A, van der Vorst, M M J, Knibbe, C A J, Herings, R M C, de Boer, Anthonius & Mantel-Teeuwisse, A K (2015). Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands. British Journal of Clinical Pharmacology, 80 (2), (pp. 294-303) (10 p.). © 2015 The British Pharmacological Society..
Verhaegh, B.P.M., De Vries, F., Masclee, A.A., Keshavarzian, A., De Boer, A., Souverein, P., Jonkers, D.M. & Pierik, M.J. (01.02.2015). Medication-induced microscopic colitis: Do recency and duration of use matter?. Journal of Crohn's and Colitis, 9, (pp. 6-7) (2 p.).
Mahmoud Pour, Seyed Hamidreza, Asselbergs, Folkert W., Souverein, Patrick C., De Boer, Anthonius & Maitland - van der Zee, Anke-Hilse (01.09.2015). Patterns of angiotensin converting enzyme inhibitor prescriptions for different indications: A population-based study. Pharmacoepidemiology and Drug Safety, 24, (pp. 202-203) (2 p.).
Yasmina, Alfi, De Boer, Anthonius, Klungel, Olaf H. & Souverein, Patrick C. (01.09.2015). Patterns of antiplatelet use in patients with myocardial infarction and subsequent acute coronary syndrome events. Pharmacoepidemiology and Drug Safety, 24, (pp. 119) (1 p.).
Uddin, Md Jamal, Groenwold, Rolf H H, van Staa, Tjeerd P, de Boer, Anthonius, Belitser, Svetlana V, Hoes, Arno W, Roes, Kit C B & Klungel, Olaf H (01.05.2015). Performance of prior event rate ratio adjustment method in pharmacoepidemiology - a simulation study. Pharmacoepidemiology and Drug Safety, 24 (5), (pp. 468-477) (10 p.). Copyright © 2014 John Wiley & Sons, Ltd..
van Schie, Rianne M. F., Verhoef, Talitha I., de Boer, Anthonius, van der Meer, Felix J. M., Redekop, William K., Schalekamp, Tom & Maitland-Van der Zee, Anke-Hilse (03.05.2015). Pharmacogenetics of coumarin anticoagulant therapy. (22 p.). Kluwer Academic Publishers, UK.
Van Der Aa, M. P., Fazeli Farsani, S., Knibbe, C. A J, De Boer, A. & Van Der Vorst, M. M J (2015). Population-based studies on the epidemiology of insulin resistance in children. Journal of Diabetes Research, 2015.
Marvig, Camilla L., Verhoef, Talitha I., De Boer, Anthonius, Kamali, Farhad, Redekop, Ken, Pirmohamed, Munir, Daly, Ann K., Manolopoulos, Vangelis G., Wadelius, Mia, Bouvy, Marcel & Maitland-Van Der Zee, Anke H. (01.07.2015). Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants. Thrombosis Research, 136 (1), (pp. 69-75) (7 p.).
Van Hoeijen, Daniel A., Blom, Marieke T., Bardai, Abdennasser, Souverein, Patrick C., De Boer, Anthonius & Tan, Hanno L. (02.04.2015). Reduced pre-hospital and in-hospital survival rates after out-of-hospital cardiac arrest of patients with type-2 diabetes mellitus - An observational prospective community-based study. Europace, 17 (5), (pp. 753-760) (8 p.).
Yska, Jan Peter, van Roon, Eric N, de Boer, Anthonius, Leufkens, Hubert G M, Wilffert, Bob, de Heide, Loek J M, de Vries, Frank & Lalmohamed, Arief (30.09.2015). Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery - A Population-Based Cohort Study in the United Kingdom. JAMA Surgery, (pp. 1-8) (8 p.).
Alharbi, Fawaz F., Souverein, Patrick C., De Groot, Mark C.H., Der Zee, Anke H Maitland-Van, De Boer, Anthonius & Klungel, Olaf H. (01.09.2015). The risk of acute myocardial infarction after discontinuation of antihypertensive agents. Pharmacoepidemiology and Drug Safety, 24, (pp. 199-200) (2 p.).
Bronsveld, Heleen K, ter Braak, Bas, Karlstad, Øystein, Vestergaard, Peter, Starup-Linde, Jakob, Bazelier, Marloes T, De Bruin, Marie L, de Boer, Anthonius, Siezen, Christine L E, van de Water, Bob, van der Laan, Jan Willem & Schmidt, Marjanka K (2015). Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence. Breast Cancer Research, 17 (1) (21 p.).
Alharbi, Fawaz F., Souverein, Patrick C., Blom, Marieke T., Tan, Hanno L., De Boer, Anthonius & Klungel, Olaf H. (01.09.2015). Use of antihypertensive agents and the risk of out-of-hospital cardiac arrest: A case control study. Pharmacoepidemiology and Drug Safety, 24, (pp. 200) (1 p.).
van der Zanden, Rogier, de Vries, Frank, Lalmohamed, Arief, Driessen, Johanna H M, de Boer, Anthonius, Rohde, Gernot, Neef, Cornelis & den Heijer, Casper (2015). Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia - A Population-Based Cohort Study. PLoS One, 10 (10), (pp. e0139367).
  2014 - Scholarly publications
Bergmeijer, T.O., Janssen, P.W.A., Asselbergs, F.W., Schipper, J.C., Van 'T Hof, A.W., Dewilde, W.J.M., Postma, M.J., De Boer, A., Deneer, V.H.M. & Ten Berg, J.M. (01.09.2014). A tailored antiplatelet strategy in STEMI patients based on CYP2C19 genotyping is feasible in daily practice-POPular Genetics study. European Heart Journal, 35, (pp. 191-192) (2 p.).
Yasmina, A, Deneer, V H M, Maitland-van der Zee, A H, van Staa, T P, de Boer, A & Klungel, O H (2014). Application of routine electronic health record databases for pharmacogenetic research. Journal of Internal Medicine, 275 (6), (pp. 590-604) (15 p.). © 2014 The Association for the Publication of the Journal of Internal Medicine..
Schmidt, Amand F, Klugkist, Irene, Klungel, Olaf H, Nielen, Mirjam, de Boer, Anthonius, Hoes, Arno W & Groenwold, Rolf H H (28.11.2014). Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTs. Journal of Clinical Epidemiology, 68 (4), (pp. 387-396) (10 p.). Copyright © 2015 Elsevier Inc. All rights reserved..
Verhoef, Talitha I, Redekop, W Ken, Bouvy, Marcel L, Dorenbos, Brenda, Karwar, Zamiera, van Schie, Rianne M F, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse & , (2014). Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users. British Journal of Clinical Pharmacology, 78 (2), (pp. 422-429) (8 p.). © 2014 The British Pharmacological Society..
Lalmohamed, Arief, Vestergaard, Peter, de Boer, Anthonius, Leufkens, Hubertus G M, van Staa, Tjeerd P & de Vries, Frank (2014). Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study. Arthritis and Rheumatology, 66 (2), (pp. 311-8) (8 p.).
Leusink, M., Onland-Moret, N. C., Asselbergs, F. W., Ding, B., Kotti, S., Van Zuydam, N. R., Papp, A. C., Danchin, N., Donnelly, L., Morris, A. D., Chasman, D. I., Doevendans, P. A F M, Klungel, O. H., Ridker, P. M., Van Gilst, W. H., Simon, T., Nyberg, F., Palmer, C. N A, Sadee, W., Van Der Harst, P., De Bakker, P. I W, De Boer, A., Verstuyft, C. & Maitland-Van Der Zee, A. H. (01.03.2014). Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular events. Clinical Pharmacology and Therapeutics, 95 (3), (pp. 314-320) (7 p.).
Verhoef, Talitha I, Redekop, William K, Hasrat, Fazila, de Boer, Anthonius & Maitland-van der Zee, Anke Hilse (2014). Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings. American Journal of Cardiovascular Drugs, 14 (6), (pp. 451-62) (12 p.).
Bergmeijer, Thomas O, Janssen, Paul W A, Schipper, Jurjan C, Qaderdan, Khalid, Ishak, Maycel, Ruitenbeek, Rianne S, Asselbergs, Folkert W, van 't Hof, Arnoud W J, Dewilde, Willem J M, Spanó, Fabrizio, Herrman, Jean-Paul R, Kelder, Johannes C, Postma, Maarten J, de Boer, Anthonius, Deneer, Vera H M & ten Berg, Jurriën M (2014). CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. American Heart Journal, 168 (1), (pp. 16-22.e1).
Fazelifarsani, Soulmaz, Souverein, Patrick C, van der Vorst, Marja M J, Mantel-Teeuwisse, Aukje K, Knibbe, Catherijne A J & de Boer, Anthonius (2014). Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults - an explorative case control study. PLoS One, 9 (2), (pp. e87408).
Maitland-Van Der Zee, A.H., Daly, A.K., Kamali, F., Manolopoulous, V.G., Verhoef, T.I., Wadelius, M., De Boer, A. & Pirmohamed, M. (01.09.2014). Erratum: Patients benefit from genetics-guided coumarin anticoagulant therapy (Clinical Pharmacology and Therapeutics (2014) 96:1 (15-17) DOI:10.1038/clpt.2014.44). Clinical Pharmacology and Therapeutics, 96 (3), (pp. 397) (1 p.).
Taghipour Bazargani, Y., Ewen, Margaret, de Boer, Anthonius, Leufkens, Hubert G M & Mantel-Teeuwisse, Aukje K (2014). Essential medicines are more available than other medicines around the globe. PLoS One, 9 (2) (7 p.).
Taghipour Bazargani, Y., de Boer, Anthonius, Leufkens, Hubert G M & Mantel-Teeuwisse, Aukje K (2014). Essential medicines for COPD and asthma in low and middle-income countries. Thorax, 69 (12), (pp. 1149-51) (3 p.). Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions..
van Schie, R. M F, de Boer, A. & Maitland-van der Zee, A. H. (2014). Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses - Reply. Journal of Thrombosis and Haemostasis, 12 (7), (pp. 1197-1198) (2 p.).
Schmidt, Amand F., Groenwold, Rolf H.H., Knol, Mirjam J., Hoes, Arno W., Nielen, Mirjam, Roes, Kit C.B., De Boer, Anthonius & Klungel, Olaf H. (01.07.2014). Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: Results from a systematic review and simulation study. Journal of Clinical Epidemiology, 67 (7), (pp. 821-829) (9 p.).
Leusink, M., Onland-Moret, N.C., De Bakker, P.I.W., De Boer, A. & Maitland-Van Der Zee, A.H. (01.09.2014). Fifteen years of statin pharmacogenetics: A systematic review. European Heart Journal, 35, (pp. 42) (1 p.).
Koster, A.S., de Boer, A. & Tjin a Tsoi, Sharon (2014). Gender differences in motivation and learning preferences of pharmacists in lifelong learning. Journal of Pharmacy and Pharmacology, 2, (pp. 608-615) (8 p.).
Blom, M T, van Hoeijen, D A, Bardai, A, Berdowski, J, Souverein, P C, De Bruin, M L, Koster, R W, de Boer, A & Tan, H L (2014). Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest - rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry. Open Heart, 1 (1) (6 p.).
Maitland-van der Zee, A.H., de Boer, Anthonius & Manolopoulos, V.G. (2014). Genotype-Guided Dosing of Vitamin K Antagonists. New England Journal of Medicine, 370 (18), (pp. 1765-1766) (2 p.).
Swerdlow, Daniel I, Preiss, David, Kuchenbaecker, Karoline B, Holmes, Michael V, Engmann, Jorgen E L, Shah, Tina, Sofat, Reecha, Stender, Stefan, Johnson, Paul C D, Scott, Robert A, Leusink, Maarten, Verweij, Niek, Sharp, Stephen J, Guo, Yiran, Giambartolomei, Claudia, Chung, Christina, Peasey, Anne, Amuzu, Antoinette, Li, KaWah, Palmen, Jutta, Howard, Philip, Cooper, Jackie A, Drenos, Fotios, Li, Yun R, Lowe, Gordon, Gallacher, John, Stewart, Marlene C W, Tzoulaki, Ioanna, Buxbaum, Sarah G, van der A, Daphne L, Forouhi, Nita G, Onland-Moret, N Charlotte, van der Schouw, Yvonne T, Schnabel, Renate B, Hubacek, Jaroslav A, Kubinova, Ruzena, Baceviciene, Migle, Tamosiunas, Abdonas, Pajak, Andrzej, Topor-Madry, Romanvan, Stepaniak, Urszula, Malyutina, Sofia, Baldassarre, Damiano, Sennblad, Bengt, Tremoli, Elena, de Faire, Ulf, Veglia, Fabrizio, Ford, Ian, Jukema, J Wouter, Westendorp, Rudi G J, de Borst, Gert Jan, de Jong, Pim A, Algra, Ale, Spiering, Wilko, der Zee, Anke H Maitland-van, Klungel, Olaf H, de Boer, Anthonius, Doevendans, Pieter A, Eaton, Charles B, Robinson, Jennifer G, Duggan, David, Kjekshus, John, Downs, John R, Gotto, Antonio M, Keech, Anthony C, Marchioli, Roberto, Tognoni, Gianni, Sever, Peter S, Poulter, Neil R, Waters, David D, Pedersen, Terje R, Amarenco, Pierre, Nakamura, Haruo, McMurray, John J V, Lewsey, James D, Chasman, Daniel I, Ridker, Paul M, Maggioni, Aldo P, Tavazzi, Luigi, Ray, Kausik K, Seshasai, Sreenivasa Rao Kondapally, Manson, JoAnn E, Price, Jackie F, Whincup, Peter H, Morris, Richard W, Lawlor, Debbie A, Smith, George Davey, Ben-Shlomo, Yoav, Schreiner, Pamela J, Fornage, Myriam, Siscovick, David S, Cushman, Mary, Kumari, Meena, Wareham, Nick J, Verschuren, W M Monique, Redline, Susan, Patel, Sanjay R, Whittaker, John C, Hamsten, Anders, Delaney, Joseph A, Dale, Caroline, Gaunt, Tom R, Wong, Andrew, Kuh, Diana, Hardy, Rebecca, Kathiresan, Sekar, Castillo, Berta A, van der Harst, Pim, Brunner, Eric J, Tybjaerg-Hansen, Anne, Marmot, Michael G, Krauss, Ronald M, Tsai, Michael, Coresh, Josef, Hoogeveen, Ronald C, Psaty, Bruce M, Lange, Leslie A, Hakonarson, Hakon, Dudbridge, Frank, Humphries, Steve E, Talmud, Philippa J, Kivimäki, Mika, Timpson, Nicholas J, Langenberg, Claudia, Asselbergs, Folkert W, Voevoda, Mikhail, Bobak, Martin, Pikhart, Hynek, Wilson, James G, Reiner, Alex P, Keating, Brendan J, Hingorani, Aroon D, Sattar, Naveed & , (24.09.2014). HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight - evidence from genetic analysis and randomised trials. The Lancet Copyright © 2014 Swerdlow et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved..
van der Aa, Marloes P, Fazeli Farsani, Soulmaz, Kromwijk, Lisa A J, de Boer, Anthonius, Knibbe, Catherijne A J & van der Vorst, Marja M J (2014). How to screen obese children at risk for type 2 diabetes mellitus?. Clinical Pediatrics, 53 (4), (pp. 337-342) (6 p.).
Wilffert, B., Swen, J.J., Mulder, H., van Schaik, R.H.N., Nijenhuis, M., Grandia, L., Maitland-van der Zee, A.H., Rongen, G.A., Schalekamp, T., van der Weide, J., de Boer, A., Guchelaar, H.J., Touw, D.J. & Deneer, V.H.M. (2014). Implementation of pharmacogenetics in evidence-based medicine: Toward advancing personalized medicine. Handbook of personalized medicine. Advances in Nanotechnology, Drug Delivery and Theory (pp. 953-1116) (164 p.). Ioannis S. Vizirianakis Pan Stanford Publishing.
Duijnhoven, R.G., Straus, S.M.J.M., Souverein, P.C., de Boer, A., Bosch, J.L.H.R., Hoes, A.W. & De Bruin, M.L. (2014). Long-term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer. Cancer Causes and Control, 25 (11), (pp. 1577-1582) (6 p.).
Leusink, Maarten, De Keyser, Catherine E., Onland-Moret, N. Charlotte, Hofman, Albert, Visser, Loes E., Stricker, Bruno H., De Bakker, Paul I W, De. Boer, Anthonius, Van Schaik, Ron H N & Maitland-Van Der Zee, Anke Hilse (01.01.2014). No association between CYP3A4∗22 and statin effectiveness in reducing the risk for myocardial infarction. Pharmacogenomics, 15 (11), (pp. 1471-1477) (7 p.).
Prieto-Alhambra, Daniel, Lalmohamed, Arief, Abrahamsen, Bo, Arden, Nigel K, de Boer, Anthonius, Vestergaard, Peter & de Vries, Frank (2014). Oral bisphosphonate use and total knee/hip implant survival - validation of results in an external population-based cohort. Arthritis and Rheumatology, 66 (11), (pp. 3233-40) (8 p.). Copyright © 2014 by the American College of Rheumatology..
Maitland-Van Der Zee, A. H., Daly, A. K., Kamali, F., Manolopoulous, V. G., Verhoef, T. I., Wadelius, M., De Boer, A. & Pirmohamed, M. (01.01.2014). Patients benefit from genetics-guided coumarin anticoagulant therapy. Clinical Pharmacology and Therapeutics, 96 (1), (pp. 15-17) (3 p.).
Uddin, Md. Jamal, Groenwold, Rolf H. H., de Boer, Anthonius, Belitser, Svetlana V., Roes, Kit C. B., Hoes, Arno W. & Klungel, Olaf H. (2014). Performance of instrumental variable methods in cohort and nested case-control studies: A simulation study. Pharmacoepidemiology and Drug Safety, 23 (2), (pp. 165-177) (13 p.).
Verhoef, Talitha I., Redekop, William K., Daly, Ann K., Van Schie, Rianne M F, De Boer, Anthonius & Maitland-Van Der Zee, Anke Hilse (2014). Pharmacogenetic-guided dosing of coumarin anticoagulants - Algorithms for warfarin, acenocoumarol and phenprocoumon. British Journal of Clinical Pharmacology, 77 (4), (pp. 626-641) (16 p.). Special Issue: Pharmacogenomics and Pharmacoepigenetics.
Yasmina Noorsyahdy, Alfi, de Boer, Anthonius, Klungel, Olaf H & Deneer, Vera H M (2014). Pharmacogenomics of oral antiplatelet drugs. Pharmacogenomics, 15 (4), (pp. 509-28) (20 p.).
van der Zee, P A & de Boer, A (01.05.2014). Pheochromocytoma - a review on preoperative treatment with phenoxybenzamine or doxazosin. Netherlands Journal of Medicine, 72 (4), (pp. 190-201) (12 p.).
Fazeli Farsani, S., Souverein, Patrick C, van der Vorst, Marja M J, Knibbe, Catherijne A J, de Boer, Anthonius & Mantel - Teeuwisse, Aukje (01.08.2014). Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents. Antimicrobial Agents and Chemotherapy, 58 (8), (pp. 4666-4674) (9 p.). Copyright © 2014, American Society for Microbiology. All Rights Reserved..
Ali, M. Sanni, Groenwold, Rolf H H, Pestman, Wiebe R., Belitser, Svetlana V., Roes, Kit C B, Hoes, Arno W., de Boer, Anthonius & Klungel, Olaf H. (2014). Propensity score balance measures in pharmacoepidemiology: A simulation study. Pharmacoepidemiology and Drug Safety, 23 (8), (pp. 802-811) (10 p.).
Warnier, M.J., Holtkamp, F.A., Rutten, F.H., Hoes, A.W., de Boer, A., Mol, P.G.M. & de Bruin, M.L. (2014). Quality of drug label information on QT interval prolongation. International Journal of Risk and Safety in Medicine, 26 (2), (pp. 89-98) (10 p.).
Van Hoeijen, Daniel A., Blom, Marieke T., Bardai, Abdennasser, Souverein, Patrick C., De Boer, Anthonius & Tan, Hanno L. (25.11.2014). Reduced prehospital survival rate after out-of-hospital cardiac arrest in patients with diabetes mellitus type 2: A prospective community-based study. Circulation, 130.
Warnier, Miriam J., Rutten, Frans H., De Boer, Anthonius, Hoes, Arno W. & De Bruin, Marie L. (26.08.2014). Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia. PLoS One, 9 (8) (7 p.).
Pouwels, Sander, de Boer, Anthonius, Leufkens, Hubert G M, Weber, Wim E J, Cooper, Cyrus & de Vries, Frank (2014). Risk of fracture in patients with Charcot-Marie-Tooth disease. Muscle and Nerve, 50 (6), (pp. 919-24) (6 p.). © 2014 Wiley Periodicals, Inc..
Pouwels, S, de Boer, A, Leufkens, H G M, Weber, W E J, Cooper, C, van Staa, T P & de Vries, F (2014). Risk of fracture in patients with Guillain-Barré syndrome. Osteoporosis International, 25 (7), (pp. 1845-51) (7 p.).
Pouwels, S, de Boer, A, Leufkens, H G M, Weber, W E J, Cooper, C, van Onzenoort, H A W & de Vries, F (2014). Risk of fracture in patients with muscular dystrophies. Osteoporosis International, 25 (2), (pp. 509-518) (10 p.).
Warnier, Miriam J., Holtkamp, Frank A., Rutten, Frans H., Hoes, Arno W., de Boer, Anthonius, Mol, Peter G M & De Bruin, Marie L. (2014). Safety information on QT-interval prolongation - comparison of European Union and United States drug labeling. Drug Discovery Today, 19 (9), (pp. 1294-1297) (4 p.). Copyright © 2014 Elsevier Ltd. All rights reserved..
Taghipour Bazargani, Y., de Boer, Anthonius, Leufkens, Hubert G M & Mantel-Teeuwisse, Aukje K (2014). Selection of essential medicines for diabetes in low and middle income countries - a survey of 32 national essential medicines lists. PLoS One, 9 (9) (8 p.).
Taghipour Bazargani, Y., de Boer, A, Schellens, J H M, Leufkens, H G M & Mantel-Teeuwisse, A K (2014). Selection of oncology medicines in low- and middle-income countries. Annals of Oncology, 25 (1), (pp. 270-276) (7 p.).
Baranova, E.V., Asselbergs, F.W., de Boer, A. & Maitland-van der Zee, A.H. (2014). The COAG and EU-PACT Trials: What is the Clinical Benefit of Pharmacogenetic-Guided Coumarin Dosing During Therapy Inititiation?. Current Molecular Medicine, 14 (7), (pp. 841-848) (8 p.).
Kreeftmeijer-Vegter, Annemarie Rosan, de Boer, Anthonius, van der Vlugt-Meijer, Roselinda H & de Vries, Peter J (2014). The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children. Orphanet Journal of Rare Diseases, 9, (pp. 120).
  2014 - Professional publications
Schouten, Sharon, De Boer, Anthonius & Koster, Andries (04.07.2014). Autonomie-stimulerende leeromgeving maakt scholing effectief. Lifelong learning - Alles draait om de intrinsieke motivatie. Pharmaceutisch Weekblad, 149 (27), (pp. 20-22) (3 p.).
Schouten, S.B., de Boer, A. & Koster, A.S. (2014). Lifelong learning: alles draait om de intrinsieke motivatie. Pharmaceutisch Weekblad, 149 (27), (pp. 20-24) (5 p.).
  2013 - Scholarly publications
Verhoef, Talitha I, Ragia, Georgia, de Boer, Anthonius, Barallon, Rita, Kolovou, Genovefa, Kolovou, Vana, Konstantinides, Stavros, Le Cessie, Saskia, Maltezos, Efstratios, van der Meer, Felix J M, Redekop, William K, Remkes, Mary, Rosendaal, Frits R, van Schie, Rianne M F, Tavridou, Anna, Tziakas, Dimitrios, Wadelius, Mia, Manolopoulos, Vangelis G, Maitland-van der Zee, Anke H & , (12.12.2013). A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon. New England Journal of Medicine, 369 (24), (pp. 2304-2312) (9 p.).
Grutters, J.P., Sculpher, M., Briggs, A.H., Severens, J.L., Candel, M.J., Stahl, J.E., De Ruysscher, D., de Boer, A., Ramaekers, B.L. & Joore, M.A. (2013). Acknowledging patient heterogeneity in economic evaluation : a systematic literature review. PharmacoEconomics, 31 (2), (pp. 111-23) (13 p.).
Alhambra, Daniel Prieto, Lalmohamed, Arief, Abrahamsen, Bo, Arden, Nigel, De Boer, Anthonius, Vestergaard, Peter & De Vries, Frank (01.04.2013). Bisphosphonate use and improved implant survival: A nationwide cohort study. Rheumatology, 52, (pp. 41) (1 p.).
Prieto-Alhambra, D., Lalmohamed, A., Abrahamsen, B., Arden, N., De Boer, A., Vestergaard, P. & De Vries, F. (01.04.2013). Bisphosphonate use and improved implant survival: A nation-wide cohort study. Osteoarthritis and Cartilage, 21, (pp. 155-156) (2 p.).
Starup-Linde, Jakob, Karlstad, Oystein, Eriksen, Stine Aistrup, Vestergaard, Peter, Bronsveld, Heleen K, de Vries, Frank, Andersen, Morten, Auvinen, Anssi, Haukka, Jari, Hjellvik, Vidar, Bazelier, Marloes T, Boer, Anthonius de, Furu, Kari & De Bruin, Marie L (2013). CARING (CAncer Risk and INsulin analoGues) - the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis. Current Drug Safety, 8 (5), (pp. 296-332) (37 p.).
Starup-Linde, Jakob, Vestergaard, Peter, Karlstad, Oystein, Eriksen, Stine A., Bronsveld, Heleen K., De Vries, Frank, De Boer, Anthonius & De Bruin, Marie L. (2013). CARING: Diabetes Mellitus and Risk of Cancer - A Systematic Review and Meta-Analysis. Pharmacoepidemiology and Drug Safety, 22, (pp. 402-403).
Schmidt, Amand F., Groenwold, Rolf H.H., Pocock, Stuart, Gueyffier, Francois, Hoes, Arno W., De Boer, Anthonius, Nielen, Mirjam & Klungel, Olaf H. (01.10.2013). Comparing effectiveness estimates from randomized and nonrandomized studies, using subgroup analyses and individual patient data. Pharmacoepidemiology and Drug Safety, 22, (pp. 29-30) (2 p.).
van Schie, R.M.F., Wessels, J.A.M., le Cessie, S., de Boer, A., Schalekamp, T., van der Meer, F.J.M, Verhoef, T.I., van Meegen, E., Rosendaal, F.R. & Maitland-van der Zee, A.H. (2013). Corrigendum to: 'Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data' [Eur Heart J (2011) 32 (15): 1909-1917, doi:10.1093/eurheartj/ehr116]. European Heart Journal, 34 (24) (1 p.).
Verhoef, Talitha I, Redekop, William K, Veenstra, David L, Thariani, Rahber, Beltman, Peter A, van Schie, Rianne Mf, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse & , (2013). Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation. Pharmacogenomics, 14 (8), (pp. 869-83) (15 p.).
Kooij, Marcel, Van Wijk, B.L.G., Heerdink, E.R., De Boer, A. & Bouvy, M.L. (09.01.2013). Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Frontiers in Pharmacology, 4 MAY.
Warnier, Miriam J, Rutten, Frans H, Numans, Mattijs E, Kors, Jan A, Tan, Hanno L, de Boer, Anthonius, Hoes, Arno W & De Bruin, Marie L (2013). Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease. COPD: Journal of Chronic Obstructive Pulmonary Disease, 10 (1), (pp. 62-71) (10 p.).
Sontoredjo, Timothy A A, de Boer, Anthonius & Maitland-van der Zee, Anke H (2013). Etnische farmacogenetica. Nederlands Tijdschrift voor Geneeskunde, 157 (17), (pp. A6118).
Van Schie, Rianne, Wessels, Judith, Aoussar, Amin, Verhoef, Talitha, Schalekamp, Tom, Le Cessie, Saskia, Van Der Meer, Felix, Rosendaal, Frits, De Boer, Anthonius & Maitland-Van Der Zee, Anke-Hilse (01.10.2013). Evaluation of the effect of SNPS in CYP3A4 and CYP4F2 on the stable phenprocoumon and acenocoumarol maintenance dose. Pharmacoepidemiology and Drug Safety, 22, (pp. 327) (1 p.).
van Schie, R M F, Aoussar, A, van der Meer, F J M, de Boer, A & Maitland-van der Zee, A H (2013). Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses. Journal of Thrombosis and Haemostasis, 11 (6), (pp. 1200-3) (4 p.).
Wangge, Grace, de Boer, Anthonius, Klungel, Olaf H, Hoes, Arno W & Knol, Mirjam J (2013). Expert-opinion on non-inferiority margin - a case study of oral anti-coagulant agents for prophylaxis of venous thromboembolic events after orthopedic surgery. Thrombosis Research, 131 (4), (pp. 368-71) (4 p.).
Wangge, G., de Boer, A., Klungel, O.H., Hoes, A.W. & Knol, M.J. (2013). Expert-opinion on non-inferiority margin: a case study of oral anti-coagulant agents for prophylaxis of venous thromboembolic events after orthopedic surgery. Thrombosis Research, 131 (4), (pp. 368-71) (4 p.).
Pouwels, Sander, Bazelier, Marloes T, de Boer, Anthonius, Weber, Wim E J, Neef, C Kees, Cooper, Cyrus & de Vries, Frank (2013). Five-year fracture risk estimation in patients with Parkinson's disease. Bone, 56 (2), (pp. 266-70) (5 p.). Copyright © 2013 Elsevier Inc. All rights reserved..
Pouwels, Sander, Bazelier, Marloes T., de Boer, Anthonius, Weber, Wim E.J., Neef, C., Cooper, Cyrus & de Vries, Frank (01.10.2013). Five-year fracture risk estimation in patients with Parkinson's disease. Bone, 56 (2), (pp. 266-270) (5 p.).
Pouwels, S, de Boer, A, Javaid, M K, Hilton-Jones, D, Verschuuren, J, Cooper, C, Leufkens, H G & de Vries, F (2013). Fracture rate in patients with myasthenia gravis - the general practice research database. Osteoporosis International, 24 (2), (pp. 467-76) (10 p.).
Fazeli Farsani, S, van der Aa, M P, van der Vorst, M M J, Knibbe, C A J & de Boer, A (2013). Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents - a systematic review and evaluation of methodological approaches. Diabetologia, 56 (7), (pp. 1471-88) (18 p.).
Jansen, S., Blom, M.T., De Jonghe, A., Van Munster, B.C., De Boer, A., De Rooij, S.E., Tan, H.L. & Van Der Velde, N. (01.09.2013). Haloperidol effects on perioperative changes in QTc-duration: A prospective in-hospital study. European Geriatric Medicine, 4, (pp. 187-188) (2 p.).
Warnier, Miriam Jacoba, Blom, Marieke Tabo, Bardai, Abdennasser, Berdowksi, Jocelyn, Souverein, Patrick Cyriel, Hoes, Arno Wilhelmus, Rutten, Frans Hendrik, de Boer, Anthonius, Koster, Rudolph Willem, De Bruin, Marie Louise & Tan, Han Liong (2013). Increased risk of sudden cardiac arrest in obstructive pulmonary disease - a case-control study. PLoS One, 8 (6), (pp. 1-8) (8 p.).
Warnier, Miriam J., Holtkamp, Frank A., Rutten, Frans H., Hoes, Arno W., De Boer, Anthonius, Mol, Peter G.M. & De Bruin, Marie L. (01.10.2013). Information on QTc-interval prolongation in the summary of product characteristics. Pharmacoepidemiology and Drug Safety, 22, (pp. 248-249) (2 p.).
Warnier, M., Holtkamp, F., Rutten, F., Hoes, A., De Boer, A., Mol, P. & De Bruin, M. (01.09.2013). Information on QT-interval prolongation properties of medicinal products in the european and american drug label. Drug Safety, 36 (9), (pp. 887) (1 p.).
Duijnhoven, Ruben G., Straus, Sabine M.J.M., Souverein, Patrick C., De Boer, Anthonius, Hoes, Arno W. & De Bruin, Marie L. (01.10.2013). Male breast cancer in users of finasteride and dutasteride: A case-control study. Pharmacoepidemiology and Drug Safety, 22, (pp. 355) (1 p.).
Fazeli Farsani, S., Souverein, Patrick C., Van Der Vorst, Maria M.J., Knibbe, Catherijne A.J. & De Boer, Anthonius (01.10.2013). Medication use and disease history as risk factors for the clinical manifestation of type 1 diabetes mellitus. Pharmacoepidemiology and Drug Safety, 22, (pp. 336-337) (2 p.).
Duijnhoven, R.G., Straus, S.M.J.M., Raine, J.M., de Boer, A., Hoes, A.W. & De Bruin, M.L. (2013). Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis. PLoS Medicine, 10 (3), (pp. e1001407/1-e1001407/8) (8 p.).
Mahmoudpour, Seyed Hamidreza, Leusink, Maarten, van der Putten, Lisa, Terreehorst, Ingrid, Asselbergs, Folkert W, de Boer, Anthonius & Maitland-van der Zee, Anke H (2013). Pharmacogenetics of ACE inhibitor-induced angioedema and cough - a systematic review and meta-analysis. Pharmacogenomics, 14 (3), (pp. 249-60) (12 p.).
Bernabe, Rosemarie D L C, Wangge, Grace, Knol, Mirjam J, Klungel, Olaf H, van Delden, Johannes J M, de Boer, Anthonius, Hoes, Arno W, Raaijmakers, Jan A M & van Thiel, Ghislaine J M W (01.01.2013). Phase IV non-inferiority trials and additional claims of benefit. BMC Medical Research Methodology, 13, (pp. 70) (1 p.).
Fazeli Farsani, S., Souverein, Patrick C., Van Der Vorst, Maria M.J., Knibbe, Catherijne A.J. & De Boer, Anthonius (01.10.2013). Prevalence and patterns of anti-infective medication use in children with type 1 diabetes mellitus. Pharmacoepidemiology and Drug Safety, 22, (pp. 336) (1 p.).
Schmidt, A.F., Nielen, M., Klungel, O.H., Hoes, A.W., de Boer, A., Groenwold, R.H.H., Kirpensteijn, J. & , (01.11.2013). Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery - an individual patient data meta-analysis. Preventive Veterinary Medicine, 112 (3-4), (pp. 414-422) (9 p.). Copyright © 2013 Elsevier B.V. All rights reserved..
Lalmohamed, A, Vestergaard, P, Jansen, P A F, Grove, E L, de Boer, A, Leufkens, H G M, van Staa, T P & de Vries, F (2013). Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement. Journal of Thrombosis and Haemostasis, 11 (4), (pp. 642-50) (9 p.). © 2013 International Society on Thrombosis and Haemostasis..
Warnier, M., Holtkamp, F., Rutten, F., Hoes, A., De Boer, A., Mol, P. & De Bruin, M. (01.09.2013). Quality of label information on qt-interval prolongation of medicinal products registered in the EU. Drug Safety, 36 (9), (pp. 827) (1 p.).
Uddin, M. Jamal, Ali, M. Sanni, Groenwold, Rolf H.H., Pestman, W.R., Belitser, Svetlana V., Hoes, Arno W., De Boer, Anthonius, Roes, Kit C.B. & Klungel, Olaf H. (15.06.2013). Quantitative verification of instrumental variables assumption using balance measures. American Journal of Epidemiology, 177, (pp. 102) (1 p.).
Blom, M T, Warnier, M J, Bardai, A, Berdowski, J, Koster, R W, Souverein, P C, Hoes, A W, Rutten, F H, de Boer, A, De Bruin, M L & Tan, H L (2013). Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation, 84 (5), (pp. 569-74) (6 p.). Copyright © 2012 Elsevier Ireland Ltd. All rights reserved..
Pouwels, S, Bazelier, M T, de Boer, A, Weber, W E J, Neef, C, Cooper, C & de Vries, F (2013). Risk of fracture in patients with Parkinson's disease. Osteoporosis International, 24 (8), (pp. 2283-90) (8 p.).
Lalmohamed, Arief, Vestergaard, Peter, Javaid, M Kassim, de Boer, Anthonius, Leufkens, Hubertus G M, van Staa, Tjeerd P & de Vries, Frank (2013). Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls - a nationwide cohort study. American Journal of Gastroenterology, 108 (8), (pp. 1277-85) (9 p.).
Donnelly, Louise A., Van Zuydam, Natalie R., Zhou, Kaixin, Tavendale, Roger, Carr, Fiona, Maitland-Van Der Zee, Anke H., Leusink, Maarten, De Boer, Anthonius, Doevendans, Pieter A., Asselbergs, Folkert W., Morris, Andrew D., Pearson, Ewan R., Klungel, Olaf H., Doney, Alex S.F. & Palmer, Colin N.A. (01.10.2013). Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment. Pharmacogenetics and Genomics, 23 (10), (pp. 518-525) (8 p.).
Biere-Rafi, Sara, Hutten, Barbara A, Squizzato, Alessandro, Ageno, Walter, Souverein, Patrick C, de Boer, Anton, Gerdes, Victor E A, Büller, Harry R, Kamphuisen, Pieter W & de Boer, Anthonius (2013). Statin treatment and the risk of recurrent pulmonary embolism. European Heart Journal, 34 (24), (pp. 1800-6) (7 p.).
Bardai, Abdennasser, Amin, Ahmad S, Blom, Marieke T, Bezzina, Connie R, Berdowski, Jocelyn, Langendijk, Pim N J, Beekman, Leander, Klemens, Christine A, Souverein, Patrick C, Koster, Rudolph W, de Boer, Anthonius & Tan, Hanno L (2013). Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability - evidence from bench, bedside, and community. European Heart Journal, 34 (20), (pp. 1506-16) (11 p.).
Bardai, A., Amin, A.S., Blom, M.T., Bezzina, C.R., Berdowski, J., Langendijk, P.N.J., Beekman, L., Klemens, C.A., Souverein, P.C., Koster, R.W., de Boer, A. & Tan, H.L. (2013). Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community. European Heart Journal, 34 (20), (pp. 1506-16) (11 p.).
Wangge, Grace, Roes, Kit C B, de Boer, Anthonius, Hoes, Arno W & Knol, Mirjam J (19.02.2013). The challenges of determining noninferiority margins - a case study of noninferiority randomized controlled trials of novel oral anticoagulants. CMAJ, 185 (3), (pp. 222-227) (6 p.).
Ali, M.S., Groenwold, R.H.H., Pestman, W.R., Belitser, S.V., Hoes, A.W., de Boer, A. & Klungel, O.H. (2013). Time-dependent propensity score and collider-stratification bias: an example of beta(2)-agonist use and the risk of coronary heart disease. European Journal of Epidemiology, 28 (4), (pp. 291-299) (9 p.).
Ali, Sanni, Groenwold, Rolf H.H., Pestman, Wiebe R., Belitser, S., Hoes, Arno W., De Boer, A. & Klungel, Olaf H. (01.04.2013). Time-dependent propensity score and collider-stratification bias: An example of beta2-agonist use and the risk of coronary heart disease. European Journal of Epidemiology, 28 (4), (pp. 291-299) (9 p.).
Franken, Margreet, Nilsson, Fredrik, Sandmann, Frank, de Boer, Anthonius & Koopmanschap, Marc (2013). Unravelling drug reimbursement outcomes - a comparative study of the role of pharmacoeconomic evidence in Dutch and Swedish reimbursement decision making. PharmacoEconomics, 31 (9), (pp. 781-797) (17 p.).
Stuijver, Danka J F, Majoor, Christof J, van Zaane, Bregje, Souverein, Patrick C, de Boer, Anthonius, Dekkers, Olaf M, Büller, Harry R & Gerdes, Victor E A (2013). Use of oral glucocorticoids and the risk of pulmonary embolism - a population-based case-control study. Chest, 143 (5), (pp. 1337-1342) (6 p.).
  2013 - Professional publications
Sontoredjo, T.A., de Boer, A. & Maitland-van der Zee, A.H. (2013). [Ethnicity in pharmacogenetics]. Nederlands Tijdschrift voor Geneeskunde, 157 (17) (1 p.).
Van Schie, Rianne M. F., De Boer, Anthonius, Van Der Meer, Felix J. M. & Maitland-van Der Zee, Anke-Hilse (13.09.2013). Beter doseren van coumarines door farmacogenetica. Pharmaceutische Weekblad Wetenschappelijk Platform, 148 (37).
Van Schie, Rianne M. F., De Boer, Anthonius, Van Der Meer, Felix J. M. & Maitland - van der Zee, Anke-Hilse (13.09.2013). Coumarines en farmacogenetica. Pharmaceutisch Weekblad, 148 (37), (pp. 24-27) (4 p.).
  2012 - Scholarly publications
Franken, M.G., Nilsson, F., Sandmann, F., De Boer, A. & Koopmanschap, M.A. (01.11.2012). A detailed comparison of dutch and swedish drug reimbursement decisions: What evidence is available, which criteria are used, and is the decision-making process transparent?. Value in Health, 15 (7), (pp. 287) (1 p.).
van Schie, R M F, Babajeff, A M V, Schalekamp, T, Wessels, J A M, le Cessie, S, de Boer, A, van der Meer, F J M, van Meegen, E, Verhoef, T I, Rosendaal, F R, Maitland-van der Zee, A H & , (2012). An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol. Journal of Thrombosis and Haemostasis, 10 (5), (pp. 767-772) (6 p.). © 2012 International Society on Thrombosis and Haemostasis..
Lalmohamed, A, Welsing, P M J, Lems, W F, Jacobs, J W G, Kanis, J A, Johansson, H, De Boer, A & De Vries, F (2012). Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporosis International, 23 (3), (pp. 861-9) (9 p.).
Warnier, Miriam J, Rutten, Frans H, Kors, Jan A, Lammers, Jan Willem J, de Boer, Anthonius, Hoes, Arno W & de Bruin, Marie L (2012). Cardiac arrhythmias in adult patients with asthma. Journal of Asthma, 49 (9), (pp. 942-6) (5 p.).
Lalmohamed, A, Bazelier, M T, Van Staa, T P, Uitdehaag, B M J, Leufkens, H G M, De Boer, A & De Vries, F (2012). Causes of death in patients with multiple sclerosis and matched referent subjects - a population-based cohort study. European Journal of Neurology, 19 (7), (pp. 1007-1014) (8 p.). © 2012 The Author(s) European Journal of Neurology © 2012 EFNS..
van Vliet-Ostaptchouk, Jana V, van Haeften, Timon W, Landman, Gijs W D, Reiling, Erwin, Kleefstra, Nanne, Bilo, Henk J G, Klungel, Olaf H, de Boer, Anthonius, van Diemen, Cleo C, Wijmenga, Cisca, Boezen, H Marike, Dekker, Jacqueline M, van 't Riet, Esther, Nijpels, Giel, Welschen, Laura M C, Zavrelova, Hata, Bruin, Elinda J, Elbers, Clara C, Bauer, Florianne, Onland-Moret, N Charlotte, van der Schouw, Yvonne T, Grobbee, Diederick E, Spijkerman, Annemieke M W, van der A, Daphne L, Simonis-Bik, Annemarie M, Eekhoff, Elisabeth M W, Diamant, Michaela, Kramer, Mark H H, Boomsma, Dorret I, de Geus, Eco J, Willemsen, Gonneke, Slagboom, P Eline, Hofker, Marten H & 't Hart, Leen M (2012). Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp. PLoS One, 7 (3), (pp. e32148).
Verhoef, Talitha I, Redekop, William K, van Schie, Rianne MF, Bayat, Samira, Daly, Ann K, Geitona, Mary, Haschke-Becher, Elisabeth, Hughes, Dyfrig A, Kamali, Farhad, Levin, Lars-Åke, Manolopoulos, Vangelis G, Pirmohamed, Munir, Siebert, Uwe, Stingl, Julia C, Wadelius, Mia, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse & , (2012). Cost-effectiveness of pharmacogenetics in anticoagulation - international differences in healthcare systems and costs. Pharmacogenomics, 13 (12), (pp. 1405-1417) (13 p.).
Lanktree, Matthew B., Guo, Yiran, Murtaza, Muhammed, Glessner, Joseph T., Bailey, Swneke D., Onland-Moret, N. Charlotte, Lettre, Guillaume, Ongen, Halit, Rajagopalan, Ramakrishnan, Johnson, Toby, Shen, Haiqing, Nelson, Christopher P., Klopp, Norman, Baumert, Jens, Padmanabhan, Sandosh, Pankratz, Nathan, Pankow, James S., Shah, Sonia, Taylor, Kira, Barnard, John, Peters, Bas J., Maloney, Cliona M., Lobmeyer, Maximilian T., Stanton, Alice, Zafarmand, M. Hadi, Romaine, Simon P.R., Mehta, Amar, Van Iperen, Erik P.A., Gong, Yan, Price, Tom S., Smith, Erin N., Kim, Cecilia E., Li, Yun R., Asselbergs, Folkert W., Atwood, Larry D., Bailey, Kristian M., Bhatt, Deepak, Bauer, Florianne, Behr, Elijah R., Bhangale, Tushar, Boer, Jolanda M.A., Boehm, Bernhard O., Bradfield, Jonathan P., Brown, Morris, Braund, Peter S., Burton, Paul R., Carty, Cara, Chandrupatla, Hareesh R., Chen, Wei, Connell, John, Dalgeorgou, Chrysoula, De Boer, Anthonius, Drenos, Fotios, Elbers, Clara C., Fang, James C., Fox, Caroline S., Frackelton, Edward C., Fuchs, Barry, Furlong, Clement E., Gibson, Quince, Gieger, Christian, Goel, Anuj, Grobbee, Diederik E., Hastie, Claire, Howard, Philip J., Huang, Guan-Hua, Johnson, W. Craig, Li, Qing, Kleber, Marcus E., Klein, Barbara E.K., Klein, Ronald, Kooperberg, Charles, Ky, Bonnie, Lacroix, Andrea, Lanken, Paul, Lathrop, Mark, Li, Mingyao, Marshall, Vanessa, Melander, Olle, Mentch, Frank D., Meyer, Nuala J., Monda, Keri L., Montpetit, Alexandre, Murugesan, Gurunathan, Nakayama, Karen, Nondahl, Dave, Onipinla, Abiodun, Rafelt, Suzanne, Newhouse, Stephen J., Otieno, F. George, Patel, Sanjey R., Putt, Mary E., Rodriguez, Santiago, Safa, Radwan N., Sawyer, Douglas B., Schreiner, Pamela J., Simpson, Claire, Sivapalaratnam, Suthesh, Srinivasan, Sathanur R., Suver, Christine, Swergold, Gary, Sweitzer, Nancy K., Thomas, Kelly A., Thorand, Barbara, Timpson, Nicholas J., Tischfield, Sam, Tobin, Martin, Tomaszewski, MacIej, Verschuren, W.M. Monique, Wallace, Chris, Winkelmann, Bernhard, Zhang, Haitao, Zheng, Dongling, Zhang, Li, Zmuda, Joseph M., Clarke, Robert, Balmforth, Anthony J., Danesh, John, Day, Ian N., Schork, Nicholas J., De Bakker, Paul I.W., Delles, Christian, Duggan, David, Hingorani, Aroon D., Hirschhorn, Joel N., Hofker, Marten H., Humphries, Steve E., Kivimaki, Mika, Lawlor, Debbie A., Kottke-Marchant, Kandice, Mega, Jessica L., Mitchell, Braxton D., Morrow, David A., Palmen, Jutta, Redline, Susan, Shields, Denis C., Shuldiner, Alan R., Sleiman, Patrick M., Smith, George Davey, Farrall, Martin, Jamshidi, Yalda, Christiani, David C., Casas, Juan P., Hall, Alistair S., Doevendans, Pieter A., Christie, Jason D., Berenson, Gerald S., Murray, Sarah S., Illig, Thomas, Dorn, Gerald W., Cappola, Thomas P., Boerwinkle, Eric, Sever, Peter, Rader, Daniel J., Reilly, Muredach P., Caulfield, Mark, Talmud, Philippa J., Topol, Eric, Engert, James C., Wang, Kai, Dominiczak, Anna, Hamsten, Anders, Curtis, Sean P., Silverstein, Roy L., Lange, Leslie A., Sabatine, Marc S., Trip, Mieke, Saleheen, Danish, Peden, John F., Cruickshanks, Karen J., März, Winfried, O'Connell, Jeffrey R., Klungel, Olaf H., Wijmenga, Cisca, Maitland-Van Der Zee, Anke Hilse, Schadt, Eric E., Johnson, Julie A., Jarvik, Gail P., Papanicolaou, George J., Grant, Struan F.A., Munroe, Patricia B., North, Kari E., Samani, Nilesh J., Koenig, Wolfgang, Gaunt, Tom R., Anand, Sonia S., Van Der Schouw, Yvonne T., Soranzo, Nicole, Fitzgerald, Garret A., Reiner, Alex, Hegele, Robert A., Hakonarson, Hakon & Keating, Brendan J. (08.06.2012). Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18)). American Journal of Human Genetics, 90 (6), (pp. 1116-1117) (2 p.).
van Schie, Rianne M F, Wessels, Judith A M, Verhoef, Talitha I, Schalekamp, Tom, le Cessie, Saskia, van der Meer, Felix J M, Rosendaal, Frits R, Visser, Loes E, Teichert, Martina, Hofman, Albert, Buhre, Peter N M, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2012). Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance dose. Pharmacogenomics, 13 (16), (pp. 1917-1923) (7 p.).
van Schie, Rianne M F, Verhoef, Talitha I, Boejharat, Saskia B, Schalekamp, Tom, Wessels, Judith A M, le Cessie, Saskia, Rosendaal, Frits R, van der Meer, Felix J M, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2012). Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose. Drug Metabolism and Drug Interactions, 27 (4), (pp. 229-34) (6 p.).
Saxena, Richa, Elbers, Clara C., Guo, Yiran, Peter, Inga, Gaunt, Tom R., Mega, Jessica L., Lanktree, Matthew B., Tare, Archana, Castillo, Berta Almoguera, Li, Yun R., Johnson, Toby, Bruinenberg, Marcel, Gilbert-Diamond, Diane, Rajagopalan, Ramakrishnan, Voight, Benjamin F., Balasubramanyam, Ashok, Barnard, John, Bauer, Florianne, Baumert, Jens, Bhangale, Tushar, Böhm, Bernhard O., Braund, Peter S., Burton, Paul R., Chandrupatla, Hareesh R., Clarke, Robert, Cooper-Dehoff, Rhonda M., Crook, Errol D., Davey-Smith, George, Day, Ian N., De Boer, Anthonius, De Groot, Mark C.H., Drenos, Fotios, Ferguson, Jane, Fox, Caroline S., Furlong, Clement E., Gibson, Quince, Gieger, Christian, Gilhuijs-Pederson, Lisa A., Glessner, Joseph T., Goel, Anuj, Gong, Yan, Grant, Struan F.A., Grobbee, Diederick E., Hastie, Claire, Humphries, Steve E., Kim, Cecilia E., Kivimaki, Mika, Kleber, Marcus, Meisinger, Christa, Kumari, Meena, Langaee, Taimour Y., Lawlor, Debbie A., Li, Mingyao, Lobmeyer, Maximilian T., Maitland-Van Der Zee, Anke-Hilse, Meijs, Matthijs F.L., Molony, Cliona M., Morrow, David A., Murugesan, Gurunathan, Musani, Solomon K., Nelson, Christopher P., Newhouse, Stephen J., O'Connell, Jeffery R., Padmanabhan, Sandosh, Palmen, Jutta, Patel, Sanjey R., Pepine, Carl J., Pettinger, Mary, Price, Thomas S., Rafelt, Suzanne, Ranchalis, Jane, Rasheed, Asif, Rosenthal, Elisabeth, Ruczinski, Ingo, Shah, Sonia, Shen, Haiqing, Silbernagel, Günther, Smith, Erin N., Spijkerman, Annemieke W.M., Stanton, Alice, Steffes, Michael W., Thorand, Barbara, Trip, Mieke, Van Der Harst, Pim, Van Der A, Daphne L., Van Iperen, Erik P.A., Van Setten, Jessica, Van Vliet-Ostaptchouk, Jana V., Verweij, Niek, Wolffenbuttel, Bruce H.R., Young, Taylor, Zafarmand, M. Hadi, Zmuda, Joseph M., Boehnke, Michael, Altshuler, David, McCarthy, Mark, Kao, W.H. Linda, Pankow, James S., Cappola, Thomas P., Sever, Peter, Poulter, Neil, Caulfield, Mark, Dominiczak, Anna, Shields, Denis C., Bhatt, Deepak L., Zhang, Li, Curtis, Sean P., Danesh, John, Casas, Juan P., Van Der Schouw, Yvonne T., Onland-Moret, N. Charlotte, Doevendans, Pieter A., Dorn II, Gerald W., Farrall, Martin, Fitzgerald, Garret A., Hamsten, Anders, Hegele, Robert, Hingorani, Aroon D., Hofker, Marten H., Huggins, Gordon S., Illig, Thomas, Jarvik, Gail P., Johnson, Julie A., Klungel, Olaf H., Knowler, William C., Koenig, Wolfgang, März, Winfried, Meigs, James B., Melander, Olle, Munroe, Patricia B., Mitchell, Braxton D., Bielinski, Susan J., Rader, Daniel J., Reilly, Muredach P., Rich, Stephen S., Rotter, Jerome I., Saleheen, Danish, Samani, Nilesh J., Schadt, Eric E., Shuldiner, Alan R., Silverstein, Roy, Kottke-Marchant, Kandice, Talmud, Philippa J., Watkins, Hugh, Asselbergs, Folkert W., De Bakker, Paul I.W., McCaffery, Jeanne, Wijmenga, Cisca, Sabatine, Marc S., Wilson, James G., Reiner, Alex, Bowden, Donald W., Hakonarson, Hakon, Siscovick, David S. & Keating, Brendan J. (09.03.2012). Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. American Journal of Human Genetics, 90 (3), (pp. 410-425) (16 p.).
Verhoef, T I, Redekop, W K, Hegazy, H, de Boer, A, Maitland-van der Zee, A H & , (2012). Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users. Journal of Thrombosis and Haemostasis, 10 (12), (pp. 2610-2612) (3 p.).
Verhoef, T I, Redekop, W K, Buikema, M M, Schalekamp, T, Van Der Meer, F J M, Le Cessie, S, Wessels, J A M, Van Schie, R M F, De Boer, A, Teichert, M, Visser, L E, Maitland-Van Der Zee, A H & , (2012). Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users. Journal of Thrombosis and Haemostasis, 10 (4), (pp. 606-614) (9 p.). © 2012 International Society on Thrombosis and Haemostasis..
Voight, Benjamin F, Peloso, Gina M, Orho-Melander, Marju, Frikke-Schmidt, Ruth, Barbalic, Maja, Jensen, Majken K, Hindy, George, Hólm, Hilma, Ding, Eric L, Johnson, Toby, Schunkert, Heribert, Samani, Nilesh J, Clarke, Robert, Hopewell, Jemma C, Thompson, John F, Li, Mingyao, Thorleifsson, Gudmar, Newton-Cheh, Christopher, Musunuru, Kiran, Pirruccello, James P, Saleheen, Danish, Chen, Li, Stewart, Alexandre F R, Schillert, Arne, Thorsteinsdottir, Unnur, Thorgeirsson, Gudmundur, Anand, Sonia, Engert, James C, Morgan, Thomas, Spertus, John, Stoll, Monika, Berger, Klaus, Martinelli, Nicola, Girelli, Domenico, McKeown, Pascal P, Patterson, Christopher C, Epstein, Stephen E, Devaney, Joseph, Burnett, Mary-Susan, Mooser, Vincent, Ripatti, Samuli, Surakka, Ida, Nieminen, Markku S, Sinisalo, Juha, Lokki, Marja-Liisa, Perola, Markus, Havulinna, Aki, de Faire, Ulf, Gigante, Bruna, Ingelsson, Erik, Zeller, Tanja, Wild, Philipp, de Bakker, Paul I W, Klungel, Olaf H, Maitland-van der Zee, Anke-Hilse, Peters, Bas J M, de Boer, Anthonius, Grobbee, Diederick E, Kamphuisen, Pieter W, Deneer, Vera H M, Elbers, Clara C, Onland-Moret, N Charlotte, Hofker, Marten H, Wijmenga, Cisca, Verschuren, W M Monique, Boer, Jolanda M A, van der Schouw, Yvonne T, Rasheed, Asif, Frossard, Philippe, Demissie, Serkalem, Willer, Cristen, Do, Ron, Ordovas, Jose M, Abecasis, Gonçalo R, Boehnke, Michael, Mohlke, Karen L, Daly, Mark J, Guiducci, Candace, Burtt, Noël P, Surti, Aarti, Gonzalez, Elena, Purcell, Shaun, Gabriel, Stacey, Marrugat, Jaume, Peden, John, Erdmann, Jeanette, Diemert, Patrick, Willenborg, Christina, König, Inke R, Fischer, Marcus, Hengstenberg, Christian, Ziegler, Andreas, Buysschaert, Ian, Lambrechts, Diether, Van de Werf, Frans, Fox, Keith A, El Mokhtari, Nour Eddine, Rubin, Diana, Schrezenmeir, Jürgen, Schreiber, Stefan, Schäfer, Arne, Danesh, John, Blankenberg, Stefan, Roberts, Robert, McPherson, Ruth, Watkins, Hugh, Hall, Alistair S, Overvad, Kim, Rimm, Eric, Boerwinkle, Eric, Tybjaerg-Hansen, Anne, Cupples, L Adrienne, Reilly, Muredach P, Melander, Olle, Mannucci, Pier M, Ardissino, Diego, Siscovick, David, Elosua, Roberto, Stefansson, Kari, O'Donnell, Christopher J, Salomaa, Veikko, Rader, Daniel J, Peltonen, Leena, Schwartz, Stephen M, Altshuler, David & Kathiresan, Sekar (11.08.2012). Plasma HDL cholesterol and risk of myocardial infarction - a mendelian randomisation study. The Lancet, 380 (9841), (pp. 572-80) (9 p.). Copyright © 2012 Elsevier Ltd. All rights reserved..
Kleijnen, Sarah, George, Elisabeth, Goulden, Scott, d'Andon, Anne, Vitré, Pauline, Osińska, Boguslawa, Rdzany, Rafal, Thirstrup, Steffen, Corbacho, Belen, Nagy, Bence Z, Leufkens, Hubert G, de Boer, Anthonius & Goettsch, Wim G (25.09.2012). Relative effectiveness assessment of pharmaceuticals - similarities and differences in 29 jurisdictions. Value in Health, 15 (6), (pp. 954-60) (7 p.). Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved..
Verhoef, Talitha I, Zuurhout, Miranda J L, van Schie, Rianne M F, Redekop, William K, van der Meer, Felix J M, le Cessie, Saskia, Schalekamp, Tom, de Boer, Anthonius & Maitland-van der Zee, Anke Hilse (2012). The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon. British Journal of Clinical Pharmacology, 74 (6), (pp. 1068-1069) (2 p.).
Harmsze, Ankie M., van Werkum, Jochem W., Hackeng, Christian M., Ruven, Hendrik J.T., Kelder, Johannes C., Bouman, Heleen J., Breet, Nicoline J., ten Berg, Jurriën M., Klungel, Olaf H., de Boer, Anthonius & Deneer, Vera H.M. (05.01.2012). The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting. Pharmacogenetics and Genomics, 22 (3), (pp. 169-175).
Swerdlow, D.I., Holmes, M.V., Kuchenbaecker, K.B., Engmann, J.E.L., Shah, T., Sofat, R., Guo, Y., Chung, C., Peasey, A., Pfister, R., Mooijaart, S.P., Ireland, H.A., Leusink, M., Langenberg, C., Li, K.W., Palmen, J., Howard, P., Cooper, J.A., Drenos, F., Hardy, J., Nalls, M.A., Li, Y.R., Lowe, G., Stewart, M., Bielinski, S.J., Peto, J., Timpson, N.J., Gallacher, J., Dunlop, M., Houlston, R., Tomlinson, I., Tzoulaki, I., Luan, J., Boer, J.M.A., Forouhi, N.G., Onland-Moret, N.C., van der Schouw, Y.T., Schnabel, R.B., Hubacek, J.A., Kubinova, R., Baceviciene, M., Tamosiunas, A., Pajak, A., Topor-Madry, R., Malyutina, S., Baldassarre, D., Sennblad, B., Tremoli, E., Meschia, J.F., Singleton, A., Navis, G., Leach, I.M., Bakker, S.J.L., Gansevoort, R.T., Ford, I., Epstein, S.E., Burnett, M.S., Devany, J.M., Jukema, J.W., Westendorp, R.G.J., de Borst, G.J., van der Graaf, Y., de Jong, P.A., Maitland-van der Zee, A.H., Klungel, O.H., de Boer, A., Doevendans, P.A., Stephens, J.W., Eaton, C.B., Robinson, J.G., Manson, J.E., Gerry, F., Fowkes, R., Frayling, R.M., Price, J.F., Whincup, P.H., Morris, R.W., Lawlor, D.A., Smith, G.D., Shlomo, Y.B., Redline, S., Lange, L.A., Kumari, M., Wareham, N.J., Verschuren, W.M.M., Benjamin, E.J., Whittaker, J.C., Hamsten, A., Dudbridge, F., Delaney, J.A.C., Wong, A., Kuh, D., Hardy, R., Almoguera Castillo, B., Connolly, J.J., van der Harst, P., Brunner, E.J., Marmot, M.G., Wassel, C.L., Humphries, S.E., Talmud, P.J., Kivimaki, M., Asselbergs, F.W., Voevoda, M., Bobak, M., Pikhart, H., Wilson, J.G., Hakonarson, H., Reiner, A., Keating, B.J., Sattar, N., Hingorani, A.D. & Casas, J.P. (2012). The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. The Lancet, 379 (9822), (pp. 1214-1224) (11 p.).
Lalmohamed, Arief, Vestergaard, Peter, Klop, Corinne, Grove, Erik Lerkevang, de Boer, Anthonius, Leufkens, Hubertus G M, van Staa, Tjeerd P & de Vries, Frank (10.09.2012). Timing of acute myocardial infarction in patients undergoing total hip or knee replacement - a nationwide cohort study. Archives of Internal Medicine, 172 (16), (pp. 1229-35) (7 p.).
Lalmohamed, Arief, Vestergaard, Peter, Cooper, Cyrus, de Boer, Anthonius, Leufkens, Hubertus G M, van Staa, Tjeerd P & de Vries, Frank (2012). Timing of stroke in patients undergoing total hip replacement and matched controls - a nationwide cohort study. Stroke, 43 (12), (pp. 3225-3229) (5 p.).
van Schie, Rianne M F, el Khedr, Nadia, Verhoef, Talitha I, Teichert, Martina, Stricker, Bruno H, Hofman, Albert, Buhre, Peter N, Wessels, Judith A M, Schalekamp, Tom, le Cessie, Saskia, van der Meer, Felix J M, Rosendaal, Frits R, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse & Visser, Loes E (2012). Validation of the acenocoumarol EU-PACT algorithms - similar performance in the Rotterdam Study cohort as in the original study. Pharmacogenomics, 13 (11), (pp. 1239-45) (7 p.).
  2011 - Scholarly publications
Bazelier, Marloes, de Boer, Anthonius & de Vries, Frank (2011). Acid suppressants and hip fracture - duplicate publication bias?. Bone, 49 (4), (pp. 920; author reply 921).
Groenwold, Rolf H H, de Vries, Frank, de Boer, Anthonius, Pestman, Wiebe R, Rutten, Frans H, Hoes, Arno W & Klungel, Olaf H (01.11.2011). Balance measures for propensity score methods - a clinical example on beta-agonist use and the risk of myocardial infarction. Pharmacoepidemiology and Drug Safety, 20 (11), (pp. 1130-1137) (8 p.). Copyright © 2011 John Wiley & Sons, Ltd..
Noguera, P., Posthuma-Trumpie, G.A., van Tuil, M., van der Wal, F.J., de Boer, A., Moers, A.P. & van Amerongen, A. (2011). Carbon nanoparticles in lateral flow methods to detect genes encoding virulence factors of Shiga toxin-producing Escherichia coli. Fresenius Zeitschrift fur Analytische Chemie, 399 (2), (pp. 831-8) (8 p.).
Harmsze, A.M., VanWerkum, J.W., Souverein, P.C., Bouman, H.J., Hackeng, C.M., Ruven, H.J.T., Ten Berg, J.M., Klungel, O.H., de Boer, Anthonius & Deneer, V.H.M. (01.08.2011). Combined influence of PPIs, CCBs and CYP2C19∗2 on on-treatment platelet reactivitiy and on the occurrence of atherothrombotic events in patients undergoing coronary stent implantation. European Heart Journal, 32, (pp. 239-240) (2 p.).
Harmsze, A.M., Van Werkum, J.W., Souverein, P.C., Breet, N.J., Bouman, H.J., Hackeng, C.M., Ruven, H.J.T., Ten Berg, J.M., Klungel, O.H., De Boer, A. & Deneer, V.H.M. (01.10.2011). Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. Journal of Thrombosis and Haemostasis, 9 (10), (pp. 1892-1901) (10 p.). © 2011 International Society on Thrombosis and Haemostasis..
Peters, Bas J M, Harmsze, Ankie M, ten Berg, Jurriën M, Maitland-van der Zee, Anke-Hilse, Tjoeng, Mathieu M, de Boer, Anthonius & Deneer, Vera H M (2011). CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel. Pharmacogenomics, 12 (2), (pp. 141-4) (4 p.).
Blom, Marieke T, Bardai, Abdennasser, van Munster, Barbara C, Nieuwland, Mei-Ing, de Jong, Hendrik, van Hoeijen, Daniel A, Spanjaart, Anne M, de Boer, Anthonius, de Rooij, Sophia E & Tan, Hanno L (2011). Differential changes in QTc duration during in-hospital haloperidol use. PLoS One, 6 (9), (pp. e23728).
Varekamp, I, Verbeek, J.H.A.M., de Boer, A. & van Dijk, F.J.H. (2011). Effect of job maintenance training program for employees with chronic disease - a randomized controlled trial on self-efficacy, job satisfaction, and fatigue. Scandinavian Journal of Work, Environment and Health, 37 (4), (pp. 288-97) (10 p.).
Peters, Bas J M, Pett, Helmi, Klungel, Olaf H, Stricker, Bruno H Ch, Psaty, Bruce M, Glazer, Nicole L, Wiggins, Kerri L, Bis, Josh C, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2011). Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. Atherosclerosis, 217 (2), (pp. 458-464) (7 p.). Copyright © 2011 Elsevier Ireland Ltd. All rights reserved..
Maitland-Van Der Zee, Anke-Hilse, Van Wieren-De Wijer, Diane B.M.A., De Boer, Anthonius, Kroon, Abraham A., De Leeuw, Peter W., Schiffers, Paul, Janssen, Rob G.J.H., Psaty, Bruce M., Van Duijn, Cornelia M., Stricker, Bruno H.Ch. & Klungel, Olaf H. (01.09.2011). Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 12 (3), (pp. 208-214) (7 p.).
van Schie, Rianne M F, de Boer, Anthonius & Maitland-van der Zee, Anke Hilse (2011). Implementation of pharmacogenetics in clinical practice is challenging. Pharmacogenomics, 12 (9), (pp. 1231-1233) (3 p.).
Eussen, Simone R B M, Bouvy, Marcel L, Rompelberg, Cathy J M, van der Elst, Menno E, Garssen, Johan, Oosterveld, Marco H, de Boer, Anthonius, de Gier, Johan J, van Kranen, Henk J & Klungel, Olaf H (2011). Influence of the use of functional foods enriched with phytosterols/-stanols on adherence to statin therapy. Pharmacoepidemiology and Drug Safety, 20 (8), (pp. 830-7) (8 p.). Copyright © 2011 John Wiley & Sons, Ltd..
Mattila, Taina, Stoyanova, Violeta, Elferink, André, Gispen-de Wied, Christine, de Boer, Anthonius & Wohlfarth, Tamar (2011). Insomnia medication - do published studies reflect the complete picture of efficacy and safety?. European Neuropsychopharmacology, 21 (7), (pp. 500-7) (8 p.). Copyright © 2010 Elsevier B.V. All rights reserved..
Harmsze, Ankie M, de Boer, Anthonius, Boot, Henk, Deneer, Vera H M, Heringa, Mette, Mol, Peter G M, Schalekamp, Tom, Verduijn, Monique M, Verheugt, Freek W A & le Comte, Marianne (2011). Interactie tussen clopidogrel en protonpompremmers. Nederlands Tijdschrift voor Geneeskunde, 155 (28), (pp. A2442).
van Schie, Rianne M F, Wessels, Judith A M, le Cessie, Saskia, de Boer, Anthonius, Schalekamp, Tom, van der Meer, Felix J M, Verhoef, Talitha I, van Meegen, Erik, Rosendaal, Frits R, Maitland-van der Zee, Anke-Hilse & , (2011). Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data. European Heart Journal, 32 (15), (pp. 1909-1917) (9 p.).
Belitser, S., Martens, Edwin P., Pestman, Wiebe R., Groenwold, Rolf H.H., De Boer, Anthonius & Klungel, Olaf H. (01.08.2011). Measuring balance and model selection in propensity score methods. Pharmacoepidemiology and Drug Safety, 20 (11), (pp. 1115-1129) (15 p.).
Belitser, Svetlana V, Martens, Edwin P, Pestman, Wiebe R, Groenwold, Rolf H H, de Boer, Anthonius & Klungel, Olaf H (2011). Measuring balance and model selection in propensity score methods. Pharmacoepidemiology and Drug Safety, 20 (11), (pp. 1115-1129) (15 p.). Copyright © 2011 John Wiley & Sons, Ltd..
Lanktree, M.B., Guo, Y., Murtaza, M., Glessner, J.T., Bailey, S.D., Onland-Moret, N.C., Lettre, G., Ongen, H., Rajagopalan, R., Johnson, T., Shen, H., Nelson, C.P., Klopp, N., Baumert, J., Padmanabhan, S., Pankratz, N., Pankow, J.S., Shah, S., Taylor, K., Barnard, J., Peters, B.J.M., Maloney, C.M., Lobmeyer, M.T., Stanton, A, Zafarmand, M.H., Romaine, S.P., Mehta, A., van Iperen, E.P., Gong, Y, Price, T.S., Smith, E.N., Kim, C.E., Li, Y.R., Asselbergs, F.W., Atwood, L.D., Bailey, K.M., Bhatt, D., Bauer, F., Behr, E.R., Bhangale, T., Boer, J.M., Boehm, B.O., Bradfield, J.P., Brown, M., Braund, P.S., Burton, P.R., Carty, C., Chandrupatla, H.R., Chen, W., Connell, J., Dalgeorgou, C., de Boer, A., Drenos, F., Elbers, C.C., Fang, J.C., Fox, C.S., Frackelton, E.C., Fuchs, B., Furlong, C.E., Gibson, Q., Gieger, C., Goel, A., Grobbee, D.E., Hastie, C., Howard, P.J., Huang, G.H., Johnson, W.C., Li, Q., Kleber, M.E., Klein, B.E., Klein, R., Kooperberg, C., Ky, B., Lacroix, A., Lanken, P., Lathrop, M., Li, M., Marshall, V., Melander, O., Mentch, F.D., Meyer, N.J., Monda, K.L., Montpetit, A., Murugesan, G., Nakayama, K., Nondahl, D., Onipinla, A., Rafelt, S., Newhouse, S.J., Otieno, F.G., Patel, S.R., Putt, M.E., Rodriguez, S., Safa, R.N., Sawyer, D.B., Maitland-van der Zee, A.H., Klungel, O.H., de Bakker, P.I.W. & van der Schouw, Y.T. (2011). Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. American Journal of Human Genetics, 88 (1), (pp. 6-18) (13 p.).
de Peuter, Olav R, Souverein, Patrick C, Klungel, Olaf H, Büller, Harry R, de Boer, Anthonius & Kamphuisen, Pieter W (2011). Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure. European Journal of Heart Failure, 13 (2), (pp. 220-6) (7 p.).
Biere-Rafi, S., Di Nisio, M., Gerdes, V.E.A., Porreca, E., Souverein, P.C., de Boer, A., Büller, H.A. & Kamphuisen, P.W. (2011). Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism. Pharmacoepidemiology and Drug Safety, 20, (pp. 635-642) (8 p.).
Swen, J J, Nijenhuis, M, de Boer, A, Grandia, L, Maitland-van der Zee, A H, Mulder, H, Rongen, G A P J M, van Schaik, R H N, Schalekamp, T, Touw, D J, van der Weide, J, Wilffert, B, Deneer, V H M & Guchelaar, H-J (2011). Pharmacogenetics - from bench to byte--an update of guidelines. Clinical Pharmacology and Therapeutics, 89 (5), (pp. 662-673) (12 p.).
Deenen, Maarten J, Tol, Jolien, Burylo, Artur M, Doodeman, Valerie D, de Boer, Anthonius, Vincent, Andrew, Guchelaar, Henk-Jan, Smits, Paul H M, Beijnen, Jos H, Punt, Cornelis J A, Schellens, Jan H M & Cats, Annemieke (2011). Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer. Clinical Cancer Research, 17 (10), (pp. 3455-68) (14 p.). ©2011 AACR..
van den Hoek, Hester L, Bos, Willem Jan W, de Boer, Anthonius & van de Garde, Ewoudt M W (29.11.2011). Statins and prevention of infections - systematic review and meta-analysis of data from large randomised placebo controlled trials. British Medical Journal, 343, (pp. d7281).
Harmsze, A.M., van Werkum, J.W., Moral, F., Ten Berg, J.N., Hackeng, C.M., Klungel, O.H., de Boer, A. & Deneer, V.H.M. (2011). Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients. Platelets, 22 (2), (pp. 98-102) (5 p.).
De Peuter, O.R., Lip, G.Y., Souverein, P.C., Klungel, O.H., de Boer, A., Buller, H.R. & Kamphuisen, P.W. (2011). Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. European Journal of Heart Failure, 13 (5), (pp. 489-95) (7 p.).
Pouwels, S, Lalmohamed, A, Souverein, P, Cooper, C, Veldt, B J, Leufkens, H G, de Boer, A, van Staa, T & de Vries, F (2011). Use of proton pump inhibitors and risk of hip/femur fracture - a population-based case-control study. Osteoporosis International, 22 (3), (pp. 903-10) (8 p.).
de Boer, Anthonius (2011). When to publish measures of disproportionality derived from spontaneous reporting databases?. British Journal of Clinical Pharmacology, 72 (6), (pp. 909-911) (3 p.).
  2011 - Professional publications
Harmsze, A.M., van Werkum, J.W., ten Berg, J.M., Ruven, H.J.T., Hackeng, C.M., Tjoeng, M.M., Klungel, O.H., de Boer, A. & Deneer, V.H.M. (2011). Effect van genetische variaties op de effectiviteit van clopidogrel. Pharmaceutisch Weekblad - Scientific Edition, 5 (5), (pp. a1111) (1 p.).
Harmsze, A.M., de Boer, A., Boot, H., Deneer, V.H.M., Heringa, M., Mol, P.G.M., Schalekamp, T., Verduijn, M.M., Verheugt, F.W.A. & le Comte, M. (2011). Interactie tussen clopidrogel en protonpompremmers. Nederlands Tijdschrift voor Geneeskunde, 155 (A2442).
  2010 - Scholarly publications
Eussen, Simone R.B.M., Van Der Elst, Menno E., Klungel, Olaf H., Rompelberg, Cathy J.M., Garssen, Johan, Oosterveld, Marco H., De Boer, Anthonius, De Gier, Johan J. & Bouvy, Marcel L. (01.12.2010). A pharmaceutical care program to improve adherence to statin therapy: A randomized controlled trial. Annals of Pharmacotherapy, 44 (12), (pp. 1905-1913) (9 p.).
Eussen, Simone, Van Der Elst, Menno, Klungel, Olaf, Rompelberg, Cathy, Garssen, Johan, Oosterveld, Marco, De Boer, Anthonius, De Gier, Johan & Bouvy, Marcel (01.08.2010). A randomized controlled trial of the effect of a pharmaceutical care program on improving adherence to statin therapy: The statin intervention research project (STIPT). Pharmacoepidemiology and Drug Safety, 19, (pp. 35-36) (2 p.).
Verhoef, Talitha I, Redekop, William K, Darba, Josep, Geitona, Mary, Hughes, Dyfrig A, Siebert, Uwe, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse, Barallon, Rita, Briz, Montserrat, Daly, Ann, Haschke-Becher, Elisabeth, Kamali, Farhad, Kirchheiner, Julia, Manolopoulos, Vangelis G, Pirmohamed, Munir, Rosendaal, Frits R, van Schie, Rianne M F, Wadelius, Mia & , (2010). A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Pharmacogenomics, 11 (7), (pp. 989-1002) (14 p.).
Harmsze, Ankie, van Werkum, Jochem W, Bouman, Heleen J, Ruven, Henk J, Breet, Nicolien J, Ten Berg, Jurrien M, Hackeng, Christian M, Tjoeng, Mathieu M, Klungel, Olaf H, de Boer, Anthonius & Deneer, Vera H (2010). Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation. Pharmacogenetics and Genomics, 20 (1), (pp. 18-25) (8 p.).
Verhoef, Talitha I, Schalekamp, Tom, Redekop, William K, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2010). Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin. Expert Review of Pharmacoeconomics and Outcomes Research, 10 (4), (pp. 375-378) (4 p.).
Harmsze, A.M., van Werkum, J.W., ten Berg, J.M., Zwart, B., Bouman, H.J., Breet, N.J., van 't Hof, A.W., Ruven, H.J., Hackeng, C.M., Klungel, O.H., de Boer, A. & Deneer, V.H.M. (2010). CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. European Heart Journal, 31 (24), (pp. 3046-3053) (8 p.).
Taverne, Kim, de Groot, Mark, de Boer, Anthonius & Klungel, Olaf (2010). Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs. Expert Opinion on Drug Metabolism and Toxicology, 6 (4), (pp. 439-60) (22 p.).
Harmsze, Ankie M, Deneer, Vera H, Maitland-van der Zee, Anke Hilse, de Boer, Anthonius & Klungel, Olaf H (2010). Genetische variaties beïnvloeden effectiviteit en veiligheid van geneesmiddelen. Nederlands Tijdschrift voor Geneeskunde, 154 (A1503), (pp. A1503).
Egberts, Toine & de Boer, Anthonius (2010). Gescheiden farmaceutische budgetten - dansen over ijsschotsen. Nederlands Tijdschrift voor Geneeskunde, 154 (51-52), (pp. A3004).
Mattila, Taina K & de Boer, Anthonius (03.12.2010). Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus. Drugs, 70 (17), (pp. 2229-2245) (17 p.).
Wangge, G, Klungel, O H, Roes, K C B, de Boer, A, Hoes, A W & Knol, M J (2010). Interpretation and inference in noninferiority randomized controlled trials in drug research. Clinical Pharmacology and Therapeutics, 88 (3), (pp. 420-423) (4 p.).
Peters, Bas J M, Rodin, Andrei S, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2010). Methodological and statistical issues in pharmacogenomics. Journal of Pharmacy and Pharmacology, 62 (2), (pp. 161-166) (6 p.).
Peters, Bas J M, Rodin, Andrei S, Klungel, Olaf H, van Duijn, Cornelia M, Stricker, Bruno H Ch, van't Slot, Ruben, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2010). Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction. Pharmacogenomics, 11 (8), (pp. 1065-1076) (12 p.).
Schalekamp, Tom & de Boer, Anthonius (2010). Pharmacogenetics of Oral Anticoagulant Therapy. Current Pharmaceutical Design, 16 (2), (pp. 187-203) (17 p.).
Pouwels, S., Lalmohamed, A., Leufkens, H.G.M., de Boer, A., Cooper, C., van Staa, T.P. & de Vries, F. (2010). Response to Letter by Tsuda. Stroke, 41 (1), (pp. e60-e60) (1 p.).
Wangge, Grace, Klungel, Olaf H, Roes, Kit C B, de Boer, Anthonius, Hoes, Arno W & Knol, Mirjam J (27.10.2010). Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs - a systematic review. PLoS One, 5 (10), (pp. e13550) (1 p.).
Dekkers, O M, Romijn, J A, de Boer, A & Vandenbroucke, J P (2010). The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary, 13 (3), (pp. 195-198) (4 p.).
Harmsze, A.M., Robijns, K., van Werkum, J.W., Breet, N.J., Hackeng, C.M., ten Berg, J.M., Ruven, H.J.T., Klungel, O.H., de Boer, A. & Deneer, V.H.M. (2010). The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response. Thrombosis and Haemostasis, 103, (pp. 920-925) (6 p.).
Pouwels, Sander, Lalmohamed, Arief, van Staa, Tjeerd, Cooper, Cyrus, Souverein, Patrick, Leufkens, Hubertus G, Rejnmark, Lars, de Boer, Anthonius, Vestergaard, Peter & de Vries, Frank (2010). Use of organic nitrates and the risk of hip fracture - a population-based case-control study. Journal of Clinical Endocrinology and Metabolism, 95 (4), (pp. 1924-31) (8 p.).
Peters, B.J.M., Rodin, A.S., Klungel, O.H., Stricker, B.H.Ch, Bruno, H.Ch., de Boer, A. & Maitland-van der Zee, A.H. (2010). Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction. Pharmacogenetics and Genomics, 20 (12), (pp. 766-774) (9 p.).
  2009 - Scholarly publications
van Wieren-de Wijer, D B M A, Maitland-van der Zee, A H, de Boer, A, Belitser, S V, Kroon, A A, de Leeuw, P W, Schiffers, P, Janssen, R G J H, van Duijn, C M, Stricker, B H C H & Klungel, O H (2009). Determinants of DNA yield and purity collected with buccal cell samples. European Journal of Epidemiology, 24 (11), (pp. 677-82) (6 p.).
Kars, M, Souverein, P.C., Herings, R.M.C., Romijn, J.A., Vandenbroucke, J.P., de Boer, A. & Dekkers, O.M. (2009). Estimated Age- and Sex-Specific Incidence and Prevalence of Dopamine Agonist-Treated Hyperprolactenemia. Journal of Clinical Endocrinology and Metabolism, 94 (8), (pp. 2729-2734) (6 p.).
Kars, M, Souverein, P C, Herings, R M C, Romijn, J A, Vandenbroucke, J P, de Boer, A & Dekkers, O M (2009). Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 94 (8), (pp. 2729-34) (6 p.).
Peters, Bas J M, Klungel, Olaf H, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2009). Genetic determinants of response to statins. Expert Review of Cardiovascular Therapy, 7 (8), (pp. 977-983) (7 p.).
van Schie, Rianne M F, Wadelius, M I A, Kamali, Farhad, Daly, Ann K, Manolopoulos, Vangelis G, de Boer, Anthonius, Barallon, Rita, Verhoef, Talitha I, Kirchheiner, Julia, Haschke-Becher, Elisabeth, Briz, Montserrat, Rosendaal, Frits R, Redekop, William K, Pirmohamed, Munir & Maitland van der Zee, Anke-Hilse (2009). Genotype-guided dosing of coumarin derivatives - the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics, 10 (10), (pp. 1687-1695) (9 p.).
van Wieren-de Wijer, B.M.A., Maitland-van der Zee, A.H., de Boer, A., Kroon, A.A., de Leeuw, P.W., Schiffers, P.M., Janssen, R.G.J.H., Psaty, B.M., van Duijn, C.M., Stricker, B.H.Ch. & Klungel, O.H. (2009). Interaction between the Fly460Trp α-adducin gene variant and diuretics on the risk of myocardial infarction. Journal of Hypertension, 27, (pp. 61-68) (8 p.).
van Wieren-de Wijer, Diane B M A, Maitland-van der Zee, Anke-Hilse, de Boer, Anthonius, Kroon, Abraham A, de Leeuw, Peter W, Schiffers, Paul, Janssen, Rob G J H, Psaty, Bruce M, van Duijn, Cornelia M, Stricker, Bruno H Ch & Klungel, Olaf H (2009). Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. Journal of Hypertension, 27 (1), (pp. 61-8) (8 p.).
Peters, Bas J M, Klungel, Olaf H, de Boer, Anthonius, Ch Stricker, Bruno H & Maitland-van der Zee, Anke-Hilse (2009). Pharmacogenetics of cardiovascular drug therapy. Clinical Cases in Mineral and Bone Metabolism, 6 (1), (pp. 55-65) (11 p.).
Peters, Bas Jm, Klungel, Olaf H, Visseren, Frank L, de Boer, Anthonius & Maitland-van der Zee, Anke-Hilse (2009). Pharmacogenomic insights into treatment and management of statin-induced myopathy. Genome Medicine, 1 (12), (pp. 120).
van Wieren-de Wijer, Diane B M A, Maitland-van der Zee, Anke-Hilse, de Boer, Anthonius, Kroon, Abraham A, de Leeuw, Peter W, Schiffers, Paul, Janssen, Rob G J H, Psaty, Bruce M, van Duijn, Cornelia M, Stricker, Bruno H Ch & Klungel, Olaf H (2009). Reasons for non-response in observational pharmacogenetic research. Pharmacoepidemiology and Drug Safety, 18 (8), (pp. 665-71) (7 p.). Copyright 2009 John Wiley & Sons, Ltd..
van Wieren-de Wijer, Diane B M A, Maitland-van der Zee, Anke-Hilse, de Boer, Anthonius, Stricker, Bruno H Ch, Kroon, Abraham A, de Leeuw, Peter W, Bozkurt, O & Klungel, Olaf H (2009). Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharmacy World and Science, 31 (2), (pp. 158-164) (7 p.).
Bozkurt, Özlem, de Boer, Anthonius, Grobbee, Diederik E, Kroon, Abraham A, Schiffers, Paul, de Leeuw, Peter & Klungel, Olaf H (2009). Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 10 (2), (pp. 101-108) (8 p.).
Pouwels, Sander, Lalmohamed, Arief, Leufkens, Bert, de Boer, Anthonius, Cooper, Cyrus, van Staa, Tjeerd & de Vries, Frank (2009). Risk of hip/femur fracture after stroke - a population-based case-control study. Stroke, 40 (10), (pp. 3281-5) (5 p.).
van Schie, Rianne M F, Jorgensen, Andrea L, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse & , (2009). Systematic review of pharmacogenetic warfarin dosing. Journal of General Internal Medicine, 24 (10), (pp. 1171).
van Schie, R.M.F., Jorgensen, A.L., de Boer, A. & Maitland-van der Zee, A.H. (2009). Systematic Review of Pharmcogenetic Warfarin Dosing. Journal of General Internal Medicine, 24 (10), (pp. 1171) (1 p.).
Schellens, J H M, Grouls, R, Guchelaar, H J, Touw, D J, Rongen, G A, de Boer, A & Van Bortel, L M (2009). The Dutch Vision of Clinical Pharmacology. Clinical Pharmacology and Therapeutics, 85 (4), (pp. 366-368) (3 p.).
Bozkurt, O., de Boer, A., Grobbee, D.E., de Leeuw, P.W., Kroon, A.A., Schiffers, P.M. & Klungel, O.H. (2009). Variation in Renin-Angiotensin System and Salt-Sensitivity Genes and the Risk of Diabetes Mellitus Associated With the Use of Thiazide Diuretics. American Journal of Hypertension, 22 (5), (pp. 545-551) (7 p.).
  2009 - Professional publications
Schalekamp, T. & de Boer, A. (2009). Farmacogenetica van cumarinederivaten. Genotypering helpt antistollingstherapie. Pharmaceutisch Weekblad, 23 oktober, (pp. 14-18) (5 p.).
van Wijk, B.L.G. & de Boer, A. (2009). Generieke geneesmiddelensubstitutie en therapietrouw. Pharmaceutisch Weekblad, 3 (1), (pp. 2-3) (2 p.).
Brassé, B.P., Chahid, Y., Roijers, J.F.M., van Geest-Daalderop, J.H.H., de Vries-Goldschmeding, H., van Wijk, E.M., de Boer, A. & Egberts, A.C.G. (2009). Invloed van de genotypen VKORC1en CYP2C9 op acenocoumarol-dosisbehoefte. Interactie tussen genotypen bepaalt overstolling. Pharmaceutisch Weekblad, 2009 (3), (pp. 4-8) (5 p.).
Klungel, O.H. & de Boer, A. (2009). Wel nadere studie nodig rol statines bij diabetes. Visie op statines blijft overeind. Pharmaceutisch Weekblad, februari, (pp. 16-20) (5 p.).
  2008 - Scholarly publications
Martens, Edwin P, de Boer, Anthonius, Pestman, Wiebe R, Belitser, Svetlana V, Stricker, Bruno H Ch & Klungel, Olaf H (2008). Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods. Pharmacoepidemiology and Drug Safety, 17 (1), (pp. 1-8) (8 p.).
Ahlers, Sabine J G M, van Gulik, Laura, van der Veen, Aletta M, van Dongen, Hendricus P A, Bruins, Peter, Belitser, Svetlana V, de Boer, Anthonius, Tibboel, Dick & Knibbe, Catherijne A J (2008). Comparison of different pain scoring systems in critically ill patients in a general ICU. Critical Care, 12 (1), (pp. R15).
Otte, Willem M, van der Maas, Frank & de Boer, Anthonius (2008). Comparison of knowledge and accessibility to information sources of HIV/AIDS between blind and sighted populations in Nigeria. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 20 (9), (pp. 1093-1097) (5 p.).
Schalekamp, Tom, Klungel, Olaf H, Souverein, Patrick C & de Boer, Anthonius (2008). Effect of oral antiplatelet agents on major bleeding in users of coumarins. Thrombosis and Haemostasis, 100 (6), (pp. 1076-1083) (8 p.).
Peters, Bas J M, Maitland-van der Zee, Anke-Hilse, Stricker, Bruno H Ch, van Wieren-de Wijer, Diane B M A, de Boer, Anthonius, Kroon, Abraham A, de Leeuw, Peter W, Schiffers, Paul, Janssen, Rob G J H, van Duijn, Cornelia M & Klungel, Olaf H (2008). Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant. Pharmacogenetics and Genomics, 18 (7), (pp. 631-636) (6 p.).
Bozkurt, O, Verschuren, W M M, van Wieren-de Wijer, B M A, Knol, M J, de Boer, A, Grobbee, D E, Geerlings, M I, Heerdink, E R & Klungel, O H (2008). Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Journal of Human Hypertension, 22 (11), (pp. 774-780) (7 p.).
Schalekamp, Tom, Klungel, Olaf H, Souverein, Patrick C & de Boer, Anthonius (28.01.2008). Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake inhibitors and Coumarins. Archives of Internal Medicine, 168 (2), (pp. 180-185) (6 p.).
Schelleman, H, Klungel, O H, Witteman, J C M, Breteler, M M B, Hofman, A, van Duijn, C M, de Boer, A & Stricker, B H Ch (2008). Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Pharmacogenomics Journal, 8 (6), (pp. 400-7) (8 p.).
Schelleman, H., Klungel, O.H., Witteman, J.C.M., Breteler, M.M.B., Hofman, A., van Duijn, C.M., de Boer, A. & Stricker, B.H.Ch. (2008). Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke. Pharmacogenomics Journal, 6 (1), (pp. 22-26) (5 p.).
Swen, J J, Wilting, I, de Goede, A L, Grandia, L, Mulder, H, Touw, D J, de Boer, A, Conemans, J M H, Egberts, T C G, Klungel, O H, Koopmans, R, van der Weide, J, Wilffert, B, Guchelaar, H-J & Deneer, V H M (2008). Pharmacogenetics - from bench to byte. Clinical Pharmacology and Therapeutics, 83 (5), (pp. 781-787) (7 p.).
Schalekamp, Tom, Maitland-van der Zee, Anke-Hilse & de Boer, Anthonius (2008). Pharmacogenomics of coumarin anticoagulants - are we underestimating the role of CYP2C9?. Thrombosis and Haemostasis, 100 (2), (pp. 175-176) (2 p.).
Martens, E.P., Pestman, W.R., de Boer, A., Belitser, S. & Klungel, O.H. (2008). Systematic differences in treatment effect estimates between propensity score methods and logistic regression. International Journal of Epidemiology, 37, (pp. 1142-1147) (6 p.).
Schellens, Jan H M, Grouls, René, Guchelaar, Henk Jan, Touw, Daan J, Rongen, Gerard A, de Boer, Anton, Van Bortel, Luc M & de Boer, Anthonius (2008). The Dutch model for clinical pharmacology - collaboration between physician- and pharmacist--clinical pharmacologists. British Journal of Clinical Pharmacology, 66 (1), (pp. 146-147) (2 p.).
  2008 - Professional publications
de Boer, A. (2008). Duidelijkheid na combinatie studies. COPD-middel veilig voor hart en vaten. Pharmaceutisch Weekblad, 50, (pp. 22-26) (5 p.).
Klungel, O.H. & de Boer, A. (2008). Publieksmedia zaaien nieuwe onrust onder statinegebruikers. Primaire preventie zinvoller dan gemeld. Pharmaceutisch Weekblad, 7, (pp. 14-16) (3 p.).
Klungel, O.H. & de Boer, A. (2008). Reacties Onderwaardering. Pharmaceutisch Weekblad, 16, (pp. 10) (1 p.).
  2007 - Scholarly publications
Schelleman, Hedi, Klungel, Olaf H, Witteman, Jacqueline C M, Breteler, Monique M B, Yazdanpanah, Moygan, Danser, A H Jan, Hofman, Albert, van Duijn, Cornelia M, de Boer, Anthonius & Stricker, Bruno H Ch (2007). Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. European Journal of Human Genetics, 15 (4), (pp. 478-484) (7 p.).
Schalekamp, Tom, van Geest-Daalderop, Johanna H H, Kramer, Mark H H, van Holten-Verzantvoort, Angelique T M & de Boer, Anthonius (2007). Coumarin anticoagulants and co-trimoxazole - avoid the combination rather than manage the interaction. European Journal of Clinical Pharmacology, 63 (4), (pp. 335-343) (9 p.).
Schelleman, H, Klungel, O H, Witteman, J C M, Breteler, M M B, Hofman, A, van Duijn, C M, de Boer, A & Stricker, B H Ch (2007). Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics Journal, 7 (5), (pp. 346-52) (7 p.).
Gumbs, Pearl D, Verschuren, Monique W M, Mantel-Teeuwisse, Aukje K, de Wit, Ardine G, de Boer, Anthonius & Klungel, Olaf H (2007). Economic evaluations of cholesterol-lowering drugs - a critical and systematic review. PharmacoEconomics, 25 (3), (pp. 187-199) (13 p.).
van der Elst, Menno E, Bouvy, Marcel L, de Blaey, Cornelis J & de Boer, Anthonius (2007). Effect of Drug Combinations On Admission For Recurrent Myocardial Infarction. Heart, 93 (10), (pp. 1226-1230) (5 p.).
Van Wijk, B.L.G., Avorn, J., Solomon, D.H., Klungel, O.H., Heerdink, E.R., de Boer, Anthonius & Brookhart, A.M. (21.09.2007). Herstarten van antihypertensiva. Pharmaceutisch Weekblad, 142 (38), (pp. 118-120) (3 p.).
Frankfort, S V, Appels, B A, de Boer, A, Tulner, L R, van Campen, J P C M, Koks, C H W, Beijnen, J H & Schmand, B A (2007). Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Pharmacoepidemiology and Drug Safety, 16 (5), (pp. 545-551) (7 p.). Copyright 2006 John Wiley & Sons, Ltd..
Schelleman, H, Klungel, O H, Witteman, J C M, Hofman, A, van Duijn, C M, de Boer, A & Stricker, B H Ch (2007). Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis. British Journal of Clinical Pharmacology, 64 (1), (pp. 57-66) (10 p.).
Bozkurt, Ozlem, de Boer, Anthonius, Grobbee, Diederick E, Heerdink, Eibert R, Burger, Huib & Klungel, Olaf H (2007). Pharmacogenetics of glucose-lowering drug treatment - a systematic review. Molecular Diagnosis and Therapy, 11 (5), (pp. 291-302) (12 p.).
Bozkurt, O., de Boer, A., Grobbee, D.E., Heerdink, E.R., Burger, H. & Klungel, O.H. (2007). Pharmacogenetics of glucose-lowering drug treatment: a systematic review. Molecular Diagnosis and Therapy, 11 (8), (pp. 291-302) (12 p.).
van Wijk, Boris L G, Avorn, Jerry, Solomon, Daniel H, Klungel, Olaf H, Heerdink, Eibert R, de Boer, Anthonius & Brookhart, Alan M (2007). Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage - a population-based study. Journal of Hypertension, 25 (3), (pp. 689-697) (9 p.).
Gumbs, Pearl D, Verschuren, W M Monique, Souverein, Patrick C, Mantel-Teeuwisse, Aukje K, de Wit, G Ardine, de Boer, Anthonius & Klungel, Olaf H (2007). Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution. British Journal of Clinical Pharmacology, 64 (5), (pp. 680-685) (6 p.).
Schalekamp, T, Brassé, B P, Roijers, J F M, van Meegen, E, van der Meer, F J M, van Wijk, E M, Egberts, A C G & de Boer, A (2007). VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status - interaction between both genotypes affects dose requirement. Clinical Pharmacology and Therapeutics, 81 (2), (pp. 185-193) (9 p.).
  2006 - Scholarly publications
Van Wijk, Boris L G, Klungel, Olaf H, Heerdink, Eibert R & de Boer, Anthonius (2006). A comparison of two multiple-characteristic decision-making models for the comparison of antihypertensive drug classes - Simple Additive Weighting (SAW) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS). American Journal of Cardiovascular Drugs, 6 (4), (pp. 251-258) (8 p.).
Maitland-Van Der Zee, Anke-Hilse, Jukema, J. Wouter, Zwinderman, Aeilko H., Hallman, D. Michael, De Boer, Anthonius, Kastelein, John J. R. & De Knijff, Peter (2006). Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS). Acta Cardiologica, 61 (3), (pp. 327-331) (5 p.).
Schalekamp, Tom, Boink, Gerard J J, Visser, Loes E, Stricker, Bruno H Ch, de Boer, Anthonius & Klungel, Olaf H (2006). CYP2C9 genotyping in acenocoumarol treatment - is it a cost-effective addition to international normalized ratio monitoring?. Clinical Pharmacology and Therapeutics, 79 (6), (pp. 511-520) (10 p.).
Schalekamp, Tom, Smit, Carolien, van Geest-Daalderop, Johanna H H, de Vries-Goldschmeding, Hanneke & de Boer, Anthonius (2006). Discrepancies between medication records of anticoagulation clinics and pharmacy records. Pharmacoepidemiology and Drug Safety, 15 (11), (pp. 823-828) (6 p.).
Schelleman, H., Klungel, O.H., Witteman, J.C.M., Breteler, M.M.B., Hofman, A., van Duijn, C.M., de Boer, A. & Stricker, B.H.Ch. (2006). Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics Journal, (pp. 1-7) (7 p.).
Gumbs, Pearl D, Verschuren, W M Monique, Mantel-Teeuwisse, Aukje K, de Wit, Ardine G, Hofman, Albert, Trienekens, Paul H, Stricker, Bruno H Ch, de Boer, Antonius, Klungel, Olaf H & de Boer, Anthonius (2006). Drug Costs Associated with Non-Adherence to Cholesterol Management Guidelines for Primary Prevention of Cardiovascular Disease in an Elderly Population - the Rotterdam study. Drugs and Aging, 23 (9), (pp. 733-741) (9 p.).
Schelleman, Hedi, Klungel, Olaf H, van Duijn, Cornelia M, Witteman, Jacqueline C M, Hofman, Albert, de Boer, Anthonius & Stricker, Bruno H Ch (2006). Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy. Annals of Pharmacotherapy, 40 (2), (pp. 212-218) (7 p.).
Van Wijk, Boris L G, Klungel, Olaf H, Heerdink, Eibert R & de Boer, Anthonius (2006). Generic substitution of antihypertensive drugs - does it affect adherence?. Annals of Pharmacotherapy, 40 (1), (pp. 15-20) (6 p.).
van der Elst, Menno E, Bouvy, Marcel L, de Blaey, Cornelis J & de Boer, Anthonius (2006). Improving pharmacotherapy after myocardial infarction by group academic detailing using feedback data on a patient level. Pharmacotherapy, 26 (2), (pp. 254-259) (6 p.).
Van Wijk, Boris L G, Klungel, Olaf H, Heerdink, Eibert R & de Boer, Anthonius (2006). Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiology and Drug Safety, 15 (8), (pp. 587-93) (7 p.). Copyright 2006 John Wiley & Sons, Ltd..
Martens, Edwin P, Pestman, Wiebe R, de Boer, Anthonius, Belitser, Svetlana V & Klungel, Olaf H (2006). Instrumental variables - application and limitations. Epidemiology, 17 (3), (pp. 260-7) (8 p.).
Martens, E.P., Pestman, W.R., de Boer, A., Belitser, S. & Klungel, O.H. (2006). Instrumental Variables. Application and limitations. Epidemiology, 17 (3), (pp. 260-267) (8 p.).
Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Hofman, Albert, Verschuren, W M Monique, Trienekens, Paul H, Porsius, Arijan J, Stricker, Bruno H Ch & de Boer, Anthonius (2006). Prescribing behaviour according to Dutch and European guidelines on the management of hypercholesterolaemia (1992-1999). British Journal of Clinical Pharmacology, 61 (5), (pp. 592-600) (9 p.).
Van Wijk, Boris L G, Klungel, Olaf H, Heerdink, Eibert R & de Boer, Anthonius (2006). Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. Journal of Clinical Epidemiology, 59 (1), (pp. 11-17) (7 p.).
Schelleman, H., Klungel, O.H., Witteman, J.C.M., Hofman, A., van Duijn, C.M., de Boer, A. & Stricker, B.H.Ch (2006). The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. European Journal of Human Genetics, 14, (pp. 860-866) (7 p.).
Frankfort, S V, Appels, B A, De Boer, A, Tulner, L R, Van Campen, J P C M, Koks, C H W & Beijnen, J H (2006). Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting. International Journal of Clinical Practice, 60 (6), (pp. 646-654) (9 p.).
Schalekamp, Tom, Brassé, Bjorn P, Roijers, Janine F M, Chahid, Youssef, van Geest-Daalderop, Johanna H H, de Vries-Goldschmeding, Hanneke, van Wijk, Eduard M, Egberts, Antoine C G & de Boer, Anthonius (2006). VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status - interaction between both genotypes affects overanticoagulation. Clinical Pharmacology and Therapeutics, 80 (1), (pp. 13-22) (10 p.).
  2006 - Professional publications
Bijl, D. & de Boer, A. (2006). Geven COX-2-remmers een betere verlichting van artroseklachten dan paracetamol?. Reumatologen Vademecum, 9 (9).
  2005 - Scholarly publications
Schillevoort, I, Herings, R M C, Hugenholtz, G W K, de Boer, A, Nolen, W A, Roos, R A C & Leufkens, H G M (2005). Antipsychotic-induced extrapyramidal syndromes in psychiatric practice - a case-control study. Pharmacy World and Science, 27 (4), (pp. 285-289) (5 p.).
Hommerson, Paul, Nedeljkovic, Srecko I, Klungel, Olaf H, de Boer, Anthonius, Ostojic, Miodrag C, Grujic, Miodrag Z, Vojvodic, Nikola M, Bloemberg, Bennie P M & Kromhout, Daan (2005). Cardiovascular drug use and differences in the incidence of cardiovascular mortality in elderly Serbian men. Pharmacy World and Science, 27 (2), (pp. 124-128) (5 p.).
Frankfort, S.V., Appels, B.A., de Boer, A., Tulner, LR, van Campen, J.P.C.M., Koks, C.H.W. & Beijnen, J.H. (2005). Discontinuation of rivastigmine in routine clincal practice. International Journal of Geriatric Psychiatry, 20, (pp. 1167-1171) (5 p.).
Frankfort, Suzanne V, Appels, Bregje A, de Boer, Anthonius, Tulner, Linda R, van Campen, Jos P C M, Koks, Cornelis H W & Beijnen, Jos H (2005). Discontinuation of rivastigmine in routine clinical practice. International Journal of Geriatric Psychiatry, 20 (12), (pp. 1167-71) (5 p.). Copyright (c) 2005 John Wiley & Sons, Ltd..
Van Wijk, Boris Lg, Klungel, Olaf H, Heerdink, Eibert R & de Boer, Anthonius (2005). Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication - a systematic review. Annals of Pharmacotherapy, 39 (2), (pp. 319-28) (10 p.).
Schalekamp, T. & de Boer, A. (2005). Effects of CYP2C9 polymorphisms on phenprocoumon anticoagulation status. Reply. International Journal of Clinical Pharmacology and Therapeutics, 77 (4), (pp. 335-336) (2 p.).
Maitland-van der Zee, A.H., Klungel, O.H. & de Boer, A. (2005). Genetic Polymorphisms and Response to HMG-CoA Reductase Inhibitors. In M.K. Raizada, J.F.R. Paton, S. Kasparov & M.J. Katovich (Eds.), Contemporary Cardiology: Cardiovascular Genomics (pp. 95-114) (362 p.). Totowa, New Jersey: Humana Press.
Schelleman, H, Klungel, O H, van Duijn, C M, Witteman, J C M, Hofman, A, de Boer, A & Stricker, B H Ch (2005). Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors. British Journal of Clinical Pharmacology, 59 (4), (pp. 483-485) (3 p.).
Schelleman, H, Stricker, B H Ch, Verschuren, W M M, de Boer, A, Kroon, A A, de Leeuw, P W, Kromhout, D & Klungel, O H (30.11.2005). Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics Journal, 6 (1), (pp. 22-26) (5 p.).
van der Elst, Menno E, Bouvy, Marcel L, de Blaey, Cornelis J & de Boer, Anthonius (2005). Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands - a retrospective analysis. Clinical Therapeutics, 27 (11), (pp. 1806-1814) (9 p.).
Van Wijk, Boris Lg, Klungel, Olaf H, Heerdink, Eibert R & de Boer, Anthonius (2005). Rate and determinants of 10-year persistence with antihypertensive drugs. Journal of Hypertension, 23 (11), (pp. 2101-2107) (7 p.).
Mantel-Teeuwisse, A.K., Klungel, O.H., Schalekamp, T., Verschuren, W.M.M., Porsius, A.J. & de Boer, A. (2005). Suboptimal choices and dosing of statins at start of therapy. British Journal of Clinical Pharmacology, 60 (1), (pp. 83-89) (7 p.).
Florentinus, Stefan R, Heerdink, Eibert R, de Boer, Antonius, van Dijk, Liset, Leufkens, Hubert G M & de Boer, Anthonius (2005). The trade-off between cardiovascular and gastrointestinal effects of rofecoxib. Pharmacoepidemiology and Drug Safety, 14 (7), (pp. 437-441) (5 p.). Copyright 2005 John Wiley & Sons, Ltd..
  2005 - Professional publications
Vader, C.I., Grouls, R.J.E., Korsten, H.H.M., Ackerman, E.W., Schonberger, J.P., de Boer, A. & Leufkens, H.G.M. (2005). Boezemfibrilleren na bypassoperatie. Pharmaceutisch Weekblad, 11, (pp. 375-378) (4 p.).
de Boer, A. (2005). Hoe nu verder met de COX-2-remmers. Geneesmiddelenbulletin, 39, (pp. 121-129) (9 p.).
Gumbs, P.D., Verschuren, W.M.M., Mantel-Teeuwisse, A.K., de Boer, A. & Klungel, O.H. (2005). Medicamenteuze behandeling van hypercholesterolemie kosteneffectief. Pharmaceutisch Weekblad, 32, (pp. 982-983) (2 p.).
Wu, H.L., Nijssen, L.E., van der Salm, A., Denee, T.R., de Boer, A. & Klungel, O.H. (2005). Statines bij acuut coronair syndroom. Pharmaceutisch Weekblad, 32, (pp. 995-997) (3 p.).
  2004 - Scholarly publications
Schalekamp, Tom, van Geest-Daalderop, Johanna H H, de Vries-Goldschmeding, Hanneke, Conemans, Jean, Bernsen Mj, M j & de Boer, Anthonius (2004). Acenocoumarol stabilization is delayed in CYP2C93 carriers. Clinical Pharmacology and Therapeutics, 75 (5), (pp. 394-402) (9 p.).
Maitland-van der Zee, Anke Hilse, Klungel, Olaf H, Stricker, Bruno H Ch, Verschuren, W M Monique, Witteman, Jacqueline C M, Stijnen, Theo, Hofman, Albert, Breteler, Monique M B, Leufkens, Hubertus G M & de Boer, Anthonius (2004). Comparison of two methodologies to analyze exposure to statins in an observational study on effectiveness. Journal of Clinical Epidemiology, 57 (3), (pp. 237-242) (6 p.).
van de Vijver, David A M C, Roos, Raymund A C, Jansen, Paul A F, Porsius, Arijan J & de Boer, Anthonius (2004). Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?. Pharmacy World and Science, 26 (5), (pp. 277-281) (5 p.).
Schelleman, Hedi, Stricker, Bruno H Ch, De Boer, Anthonius, Kroon, Abraham A, Verschuren, Monique W M, Van Duijn, Cornelia M, Psaty, Bruce M & Klungel, Olaf H (2004). Drug-Gene Interactions between Genetic Polymorphisms and Antihypertensive Therapy. Drugs, 64 (16), (pp. 1801-1816) (16 p.).
Maitland-van der Zee, Anke-Hilse, Klungel, Olaf H, Leufkens, Hubertus G M, de Boer, Anthonius, Stricker, Bruno H Ch, Hofman, Albert, Witteman, Jacqueline C M, van Duijn, Cornelia M & Kastelein, John J P (2004). Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism. Atherosclerosis, 175 (2), (pp. 377-379) (3 p.).
Schalekamp, Tom, Oosterhof, Mirjam, van Meegen, Erik, van Der Meer, Felix J M, Conemans, Jean, Hermans, Mirjam, Meijerman, Irma & de Boer, Anthonius (2004). Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status. Clinical Pharmacology and Therapeutics, 76 (5), (pp. 409-417) (9 p.).
de Maat, M M R, de Boer, A, Koks, C H W, Mulder, J W, Meenhorst, P L, van Gorp, E C M, Mairuhu, A T A, Huitema, A D R & Beijnen, J H (2004). Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. Journal of Clinical Pharmacy and Therapeutics, 29 (2), (pp. 121-130) (10 p.).
Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Egberts, Toine C G, Verschuren, W M Monique, Porsius, Arijan J & de Boer, Anthonius (2004). Failure to Continue Lipid-Lowering Drug Use Following the Withdrawal of Cerivastatin. Drug Safety, 27 (1), (pp. 63-70) (8 p.).
Mantel-Teeuwisse, A K, Goettsch, W G, Klungel, O H, de Boer, A & Herings, R M C (2004). Long term persistence with statin treatment in daily medical practice. Heart, 90 (9), (pp. 1065-1066) (2 p.).
Klungel, Olaf H, Martens, Edwin P, Psaty, Bruce M, Grobbee, Diederik E, Sullivan, Sean D, Stricker, Bruno H Ch, Leufkens, Hubert G M & de Boer, A (2004). Methods to assess intended effects of drug treatment in observational studies are reviewed. Journal of Clinical Epidemiology, 57 (12), (pp. 1223-1231) (9 p.).
Maitland-van der Zee, Anke Hilse, Klungel, Olaf H, Stricker, Bruno H Ch, Veenstra, David L, Kastelein, John J P, Hofman, Albert, Witteman, Jacqueline C M, Leufkens, Hubertus G M, van Duijn, Cornelia M & de Boer, Anthonius (2004). Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics, 14 (1), (pp. 53-60) (8 p.).
Maitland-van der Zee, A.H., Klungel, O.H., Stricker, B.H.Ch., Veenstra, D.L., Kastelein, J.J.P., Hofman, A., Witteman, J.C.M., Leufkens, H.G.M., van Duijn, C.M. & de Boer, A. (2004). Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics, 14, (pp. 53-60) (8 p.).
Maitland-van, der Zee Anke-Hilse, Klungel, Olaf H & de Boer, Anthonius (2004). Pharmacogenetics in health-care practice. Pharmacy World and Science, 26 (5), (pp. 253-5) (3 p.).
Maitland-van der Zee, A.H., Klungel, O.H. & de Boer, A. (2004). Pharmcogenetics in health-care practice. Pharmacy World and Science, 26, (pp. 253-255) (3 p.).
van Eijk, Martine E C, Paes, Arsenio H P, Porsius, Arijan, Avorn, Jerry & de Boer, Anthonius (2004). Pre-randomization decisions and group stratification in a randomized controlled trial to improve prescribing. Pharmacy World and Science, 26 (4), (pp. 227-231) (5 p.).
Schelleman, H, Klungel, O H, Kromhout, D, de Boer, A, Stricker, B H Ch & Verschuren, W M M (2004). Prevalence and determinants of undertreatment of hypertension in the Netherlands. Journal of Human Hypertension, 18 (5), (pp. 317-324) (8 p.).
Mantel-Teeuwisse, Aukje K, Verschuren, W M Monique, Klungel, Olaf H, de Boer, Anthonius & Kromhout, Daan (2004). Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands. British Journal of Clinical Pharmacology, 58 (3), (pp. 310-316) (7 p.).
Florentinus, Stefan R, Heerdink, Eibert R, Klungel, Olaf H & de Boer, Anthonius (03.11.2004). Should rosuvastatin be withdrawn from the market?. The Lancet, 364 (9445), (pp. 1577; author reply 1578-9).
Florentinus, S.R., Heerdink, E.R., Klungel, O.H. & de Boer, A. (2004). Should rosuvastatin be withdrawn from the market?. The Lancet, 364, (pp. 1577-1580) (4 p.).
van Wijk, B.L.G., Klungel, O.H., Heerdink, E.R. & de Boer, A. (2004). The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. Journal of Hypertension, 22, (pp. 1831-1837) (7 p.).
  2003 - Scholarly publications
Maitland-van der Zee, Anke-Hilse, Stricker, Bruno H Ch, Klungel, Olaf H, Mantel-Teeuwisse, Aukje K, Kastelein, John J P, Hofman, Albert, Leufkens, Hubertus G M, van Duijn, Cornelia M & de Boer, Anthonius (2003). Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes. Pharmacogenetics, 13 (4), (pp. 219-23) (5 p.).
Maitland-van der Zee, A.H., Stricker, B.H.Ch, Klungel, O.H., Mantel-Teeuwisse, A.K., Kastelein, J.J.P., Hofman, A., Leufkens, H.G.M., van Duijn, C.M. & de Boer, A. (2003). Adherence to and dosing of ß-hydroxy-ß-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes. Pharmacogenetics, 13, (pp. 219-223) (5 p.).
van der Elst, Menno E, Buurma, Henk, Bouvy, Marcel L & de Boer, Anthonius (2003). Drug therapy for prevention of recurrent myocardial infarction. Annals of Pharmacotherapy, 37 (10), (pp. 1465-77) (13 p.).
van der Elst, M.E., Buurma, H., Bouvy, M.L. & de Boer, A. (2003). Drug Therapy for Prevention of Recurrent Myocardial Infarction. Cardiology, 37, (pp. 1465-1477) (13 p.).
Maitland-van der Zee, A.H. & de Boer, A. (2003). Farmacogenetica: geneesmiddelentherapie aangepast aan het genotype van de patiënt?. Geneesmiddelenbulletin, 37 (3), (pp. 25-30) (6 p.).
Ramnath, A N, Naber, H R, de Boer, A & Leusink, J A (2003). No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting - results of a randomized clinical trial. Journal of Thoracic and Cardiovascular Surgery, 125 (6), (pp. 1432-1437) (6 p.).
van der Elst, Menno E, Cisneros-Gonzalez, Nelly, de Blaey, Cornelis J, Buurma, Henk & de Boer, Anthonius (2003). Oral Antithrombotic Use Among Myocardial Infarction Patients. Annals of Pharmacotherapy, 37 (1), (pp. 143-146) (4 p.).
de Maat, Monique M R, Post, Teun M, Jonker, Daniël M, Mulder, Jan W, Meenhorst, Pieter L, van Gorp, Eric C M, Koks, Cornelis H W, de Boer, Anthonius & Beijnen, Jos H (2003). Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001. Clinical Drug Investigation, 23 (1), (pp. 45-53) (9 p.).
Tamminga, W.J., Wemer, J., Oosterhuis, B., de Boer, A., Vranckx, S., Drenth, B.F.H., de Zeeuw, R.A., de Leij, L.F.M.H. & Jonkman, J.H.G. (2003). Polymorphic drug metabolism (CY2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study. European Journal of Clinical Pharmacology, 59, (pp. 57-64) (8 p.).
Tamminga, Wim J, Wemer, Johan, Oosterhuis, Berend, de Boer, Anthonius, Vranckx, Stan, Drenth, Ben F H, de Zeeuw, Rokus A, de Leij, Lou F M H & Jonkman, Jan H G (2003). Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients - a retrospective study. European Journal of Clinical Pharmacology, 59 (1), (pp. 57-64) (8 p.).
Maitland-van der Zee, Anke Hilse, Klungel, Olaf H, Stricker, Bruno H Ch, van der Kuip, Deirdre A M, Witteman, Jacqueline C M, Hofman, Albert, Leufkens, Hubertus G M & de Boer, Anthonius (2003). Repeated nitrate prescriptions as a potential marker for angina pectoris. A comparison with medical information from the Rotterdam Study. Pharmacy World and Science, 25 (2), (pp. 70-72) (3 p.).
Wirds, J W, Duyn, A E J, Geraerts, S D, Preijer, E, Van Diemen-Steenvoorde, J A A M, Van Leeuwen, J H Schagen, Haas, F J L M, Gerritsen, W B M, De Boer, A & Leusink, J A (2003). S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery. Archives of Disease in Childhood: Fetal and Neonatal Edition, 88 (1), (pp. F67-9) (3 p.).
Maitland-van der Zee, A.H., Stricker, B.H.Ch, Klungel, O.H., Kastelein, J.J.P., Hofman, A., Witteman, J.C.M., Breteler, M.M.B., Leufkens, H.G.M., van Duijn, C.M. & de Boer, A. (2003). The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotype. Pharmacogenetics, 12, (pp. 647-653) (7 p.).
Mantel-Teeuwisse, A.K., Verschuren, W.M.M., Klungel, O.H., Kromhout, D., Lindemans, A.D., Avorn, J., Porsius, A.J. & de Boer, A. (2003). Undertreatment of hypercholesterolaemia: a population-based study. British Journal of Clinical Pharmacology, 55, (pp. 389-397) (9 p.).
  2003 - Professional publications
de Boer, A. (2003). Klassensubstitutie van geneesmiddelen. Medicamenteuze therapie (pp. 171-176) (6 p.). Leiden: Boerhaave Commissie voor Postacademisch Onderwijs in de Gene.
Klungel, O.H., Mantel-Teeuwisse, A.K. & de Boer, A. (2003). Medicamenteuze behandeling van hypertensie en hypercholesterolemie. Sekseverschillen in epidemiologie, risico en therapie. Pharmaceutisch Weekblad, 138 (40), (pp. 1383-1389) (7 p.).
de Boer, A. (2003). Medicatiebeleid en farmaco-epidemiologie. De apotheker: uw therapeut. Pharmaceutisch Weekblad, 138 (5), (pp. 177-179) (3 p.).
  2002 - Scholarly publications
Schillevoort, Igor, de Boer, Anthonius, van der Weide, Jan, Steijns, Linda S W, Roos, Raymund A C, Jansen, Paul A F & Leufkens, Hubert G M (2002). Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype - a case-control study. Pharmacogenetics, 12 (3), (pp. 235-240) (6 p.).
Van De Vijver, D., Roos, R., Jansen, P., Porsius, A. & De Boer, A. (2002). Antipsychotics and Parkinson's disease - association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment. European Journal of Clinical Pharmacology, 58 (2), (pp. 157-161) (5 p.).
de Maat, Monique M R, Frankfort, Suzanne V, Mathôt, Ron A A, Mulder, Jan W, Meenhorst, Pieter L, van Gorp, Eric C M, Koks, Cornelis H W, Hoetelmans, Richard M W, de Boer, Anthonius & Beijnen, Jos H (2002). Discrepancies Between Medical and Pharmacy Records for Patients on Anti-HIV Drugs. Annals of Pharmacotherapy, 36 (3), (pp. 410-415) (6 p.).
van de Vijver, D.A.M.C., Hugtenburg, J.G. & De Boer, A. (03.05.2002). Epi van ziektes kinderen. Pharmaceutisch Weekblad, 137 (18), (pp. 639-643) (5 p.).
van de Vijver, D A, Roos, R A, Jansen, P A, Porsius, A J & de Boer, A (07.02.2002). Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records. Pharmacoepidemiology and Drug Safety, 10 (6), (pp. 549-554) (6 p.).
van Eijk, M E C, Belitser, S V, Porsius, A J & de Boer, A (2002). Evaluation of patient outcomes in an area where prescribing of anticholinergic antidepressants was influenced by academic detailing. Pharmacy World and Science, 24 (4), (pp. 144-148) (5 p.).
Schillevoort, I, van Puijenbroek, E P, de Boer, A, Roos, R A C, Jansen, Paul A F & Leufkens, H G M (2002). Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors - a case-control study using spontaneous reports. International Clinical Psychopharmacology, 17 (2), (pp. 75-79) (5 p.).
Maitland-van der Zee, Anke Hilse, Klungel, Olaf H, Stricker, Bruno H Ch, Monique Verschuren, W M, Kastelein, John J P, Leufkens, Hubertus G M & de Boer, Anthonius (2002). Genetic polymorphisms - importance for response to HMG-CoA reductase inhibitors. Atherosclerosis, 163 (2), (pp. 213-22) (10 p.).
van de Vijver, D A M C, Roos, R A C, Jansen, P A F, Porsius, A J & de Boer, A (2002). Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users. Acta Neurologica Scandinavica, 105 (1), (pp. 8-12) (5 p.).
Klungel, Olaf H, Heckbert, Susan R, de Boer, Anthonius, Leufkens, Hubert G M, Sullivan, Sean D, Fishman, Paul A, Veenstra, David L & Psaty, Bruce M (2002). Lipid-lowering drug use and cardiovascular events after myocardial infarction. Annals of Pharmacotherapy, 36 (5), (pp. 751-7) (7 p.).
Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Herings, Ron M C, van Puijenbroek, Eugène P, Porsius, Arijan J & de Boer, Anthonius (2002). Myopathy due to statin/fibrate use in the Netherlands. Annals of Pharmacotherapy, 36 (12), (pp. 1957-1960) (4 p.).
Stolk, L M L, Degraeuwe, P L J, Nieman, F H M, de Wolf, M C & de Boer, A (2002). Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Therapeutic Drug Monitoring, 24 (4), (pp. 527-531) (5 p.).
van de Vijver, D A M C, Roos, R A C, Jansen, P A F, Porsius, A J & de Boer, A (2002). Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. British Journal of Clinical Pharmacology, 54 (2), (pp. 168-170) (3 p.).
Maitland-van der Zee, A.H., Stricker, B.H.Ch., Klungel, O.H., Kastelein, J.J.P., Hofman, A., Witteman, J.C.M., Breteler, M.M.B., Leufkens, H.G.M., van Duijn, C.M. & de Boer, A. (2002). The effectiveness of Hydroxy-Methylglutaryl Coenzyme A reductase inhibitors in the elderly is not influenced by Apolipoprotein E-genotypes. Pharmacogenetics, 12 (8), (pp. 647-653) (7 p.).
Jansen, M.M.P.M., Heymer, F., Leusink, J.A. & de Boer, A. (2002). The quality of nutrition at an intensive care unit. Nutrition Research, 22, (pp. 411-422) (12 p.).
Mantel-Teeuwisse, A.K., Klungel, O.H., Verschuren, W.M.M., Porsius, A.J. & de Boer, A. (2002). Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?. British Journal of Clinical Pharmacology, 53, (pp. 379-385) (7 p.).
  2002 - Professional publications
Bosman, A.A.P., Van der Zee, A.H. Maitland, Klungel, O.H., Leufkens, Bert & De Boer, A. (01.03.2002). Cholesterol als risicofactor van een hersenberoerte. Pharmaceutisch Weekblad, 137 (9), (pp. 329-332) (4 p.).
Lau, H.S., Muller, J.M., Eskes, P.F., Lenters, E., Van der Westerlaken, M.M.L. & De Boer, A. (17.05.2002). Perinatale infecties. Pharmaceutisch Weekblad, 137 (20), (pp. 746-747) (2 p.).
van de Vijver, D.A.M.C., Hugtenburg, J.G. & de Boer, A. (2002). Wat hebben en gebruiken onze kleine klantjes. Pharmaceutisch Weekblad, 137 (18), (pp. 639-643) (5 p.).
  2001 - Scholarly publications
van Vliet, J., Leusink, J.A., de Jongh, B.M. & de Boer, A. (2001). A comparison between two types of central venous catheters in the prevention of catheter-related infections: the importance of performing all the relevant cultures. Clinical Intensive Care, 12 (3), (pp. 135-140) (6 p.).
Klungel, O H, Heckbert, S R, Longstreth, W T, Furberg, C D, Kaplan, R C, Smith, N L, Lemaitre, R N, Leufkens, H G, de Boer, A & Psaty, B M (08.01.2001). Antihypertensive Drug Therapies and the Risk of Ischemic Stroke. Archives of Internal Medicine, 161 (1), (pp. 37-43) (7 p.).
Schillevoort, I, de Boer, A, Herings, R M, Roos, R A, Jansen, P A & Leufkens, H G (2001). Antipsychotic-induced extrapyramidal syndromes - Risperidone compared with low- and high-potency conventional antipsychotic drugs. European Journal of Clinical Pharmacology, 57 (4), (pp. 327-331) (5 p.).
Mantel-Teeuwisse, A K, Klungel, O H, Verschuren, W M, Porsius, A & de Boer, A (2001). Comparison of different methods to estimate prevalence of drug use by using pharmacy records. Journal of Clinical Epidemiology, 54 (11), (pp. 1181-1186) (6 p.).
Klungel, O.H., Leufkens, H.G.M., de Boer, A., Longstreth, W.T., Kaplan, R.C., Smith, N.L. & Psaty, B.M. (2001). Differences Between Primary vs Secondary Prevention Trials Regarding the STroke Protective Effect of Antihypertensive Drugs. Archives of Internal Medicine, 161.
van Eijk, M E, Krist, L F, Avorn, J, Porsius, A & de Boer, A (2001). Do the research goal and databases match? A checklist for a systematic approach. Health Policy, 58 (3), (pp. 263-274) (12 p.).
Mantel-Teeuwisse, A K, Kloosterman, J M, Maitland-van der Zee, A H, Klungel, O H, Porsius, A J & de Boer, A (2001). Drug-Induced lipid changes - a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Safety, 24 (6), (pp. 443-56) (14 p.).
Mantel-Teeuwisse, A.K., Kloosterman, J.M.E., Maitland-van der Zee, A.H., Klungel, O.H., Porsius, A.J. & de Boer, A. (2001). Drug-Induces Lipid Changes. Drug Safety, 24 (6), (pp. 443-456) (14 p.).
van de Vijver, D A, Stricker, B H, Breteler, M M, Roos, R A, Porsius, A J & de Boer, A (2001). Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease. Pharmacy World and Science, 23 (4), (pp. 148-52) (5 p.).
van de Vijver, D.A.M.C., Stricker, B.H.Ch., Breteler, M.M.B., Roos, R.A.C., Porsius, A.J. & de Boer, A. (2001). Evalutation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease. Pharmacy World and Science, 23 (4), (pp. 148-152) (5 p.).
Klungel, O H, Stricker, B H, Breteler, M M, Seidell, J C, Psaty, B M & de Boer, A (2001). Is drug treatment of hypertension in clinical practice as effective as in randomized controlled trials with regard to the reduction of the incidence of stroke?. Epidemiology, 12 (3), (pp. 339-344) (6 p.).
Mantel-Teeuwisse, A.K., Klungel, O.H. & de Boer, A. (2001). Lipid abnormalities induced by novel antipsychotic drugs. Drug Safety, 24 (13), (pp. 1017-1018) (2 p.).
Maitland-van der Zee, A.H., de Boer, A. & Leufkens, H.G.M. (2001). Pharmacogenetics and the role of the pharmacist. Journal of Research in Pharmaceutical Economics, 11(3/4), (pp. 143-150) (8 p.).
van Eijk, Martine E C, Avorn, J, Porsius, A J & de Boer, A (2001). Reducing prescribing of highly anticholinergic antidepressants for elderly people - randomised trial of group versus individual academic detailing. BMJ (Clinical research ed.), 322 (7287), (pp. 654-657) (4 p.).
Schillevoort, I, de Boer, A, Herings, R M, Roos, R A, Jansen, P A & Leufkens, H G (2001). Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Annals of Pharmacotherapy, 35 (12), (pp. 1517-1522) (6 p.).
Maitland-van der Zee, A.H., Klungel, O.H., Kloosterman, J.M.E., Seidell, J.C., Leufkens, H.G.M. & de Boer, A. (2001). The association between antihypertensive drug therapies and plasma lipid levels in the general population. Journal of Human Hypertension, 15, (pp. 701-705) (5 p.).
van Dongen, E.P., Schepens, M A, Morshuis, W J, ter Beek, H T, Aarts, L P, de Boer, A & Boezeman, E H (2001). Thoracic and thoracoabdominal aortic aneurysm repair - use of evoked potential monitoring in 118 patients. Journal of Vascular Surgery, 34 (6), (pp. 1035-1040) (6 p.).
  2000 - Scholarly publications
Sang Lau, H, Riezebos, J., Abas, V., Porsius, A.J. & De Boer, A. (2000). A nation-wide study on the practice of euthanasia and physician-assisted suicide in community and hospital pharmacies in the Netherlands. Pharmacy World and Science, 22 (1), (pp. 3-9) (7 p.).
Klungel, O H, Kaplan, R C, Heckbert, S R, Smith, N L, Lemaitre, R N, Longstreth, W T, Leufkens, H G, de Boer, A & Psaty, B M (2000). Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke, 31 (2), (pp. 420-424) (5 p.).
Teeuwisse, A., Klungel, O., Porsius, A. & De Boer, A. (28.01.2000). Doelmatigheid van cholesterolverlagende geneesmiddelen. Pharmaceutisch Weekblad, 135 (4), (pp. 106) (1 p.).
Klungel, O H, de Boer, A, Paes, A H, Nagelkerke, N J, Seidell, J C & Bakker, Albert (2000). Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. Journal of Clinical Epidemiology, 53 (11), (pp. 1158-1163) (6 p.).
Klungel, O.H., Leufkens, H.G.M. & de Boer, A. (2000). Estimation of the absolute benefit of drug treatment of hypertension in the general population. Hypertension
Maitland-van der Zee, A.H., Klungel, O.H., Leufkens, H.G.M. & De Boer, A. (17.03.2000). Farmacotherapie en genotype. Pharmaceutisch Weekblad, 135 (11), (pp. 378-379) (2 p.).
Klungel, O.H., Paes, A.H.P., Seidell, J.C., Kuijvenhoven, M.M. & De Boer, A. (28.05.2000). Geslachtsverschillen behandeling hypertensie. Huisarts en Wetenschap, 43 (7), (pp. 303-305) (3 p.).
Klungel, O H, de Boer, A, Paes, A H, Nagelkerke, N J, Seidell, J C & Bakker, Albert (2000). Influence of correction for within-person variability in blood pressure on the prevalence, awareness, treatment, and control of hypertension. American Journal of Hypertension, 13 (1 ), (pp. 88-91) (4 p.).
Klungel, O H, de Boer, A, Paes, A H, Herings, R M, Seidell, J C & Bakker, Albert (2000). Influence of question structure on the recall of self-reported drug use. Journal of Clinical Epidemiology, 53 (3), (pp. 273-277) (5 p.).
Klungel, O H, Stricker, B H, Breteler, M M, Seidell, J C & de Boer, A (2000). Onderbehandeling van hypertensie en het risico op beroerte bij de oudste ouderen. Tijdschrift voor Gerontologie en Geriatrie, 31 (3), (pp. 119-122) (4 p.).
Klungel, O H, de Boer, A & Seidell, J C (2000). Overestimation of the number of individuals with hypertension who are eligible for treatment according to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine, 160 (10), (pp. 1540) (1 p.).
Klungel, O.H., Leufkens, H.G.M. & de Boer, A. (2000). Prediction or assessment of the number of averted events by treatment of hypertension. British Medical Journal
Klungel, Olaf H., Paes, Arsenio H.P., De Boer, Anthonius, Kuyvenhoven, Marijke M., Seidell, Jacob C. & Bakker, Albert (09.01.2000). Sex differences in the medication choice for hypertension in general practice: A study with written case simulations. Pharmacy World and Science, 22 (4), (pp. 140-146) (7 p.).
van de Vijver, D.A.M.C., Roos, R.A.C., Jansen, P.A.F., Porsius, A.J. & de Boer, A. (2000). Start of antidepressant drugs in Parkinson's disease: association with the disease and its course. International Journal of Geriatric Psychiatry, 2, (pp. 148-152) (5 p.).
Lau, H S, Florax, C, Porsius, A J & De Boer, A (2000). The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. British Journal of Clinical Pharmacology, 49 (6), (pp. 597-603) (7 p.).
van Dongen, E.P., ter Beek, H.T, Aarts, L.P., Schepens, M.A., Morshuis, W.J., Benning, F.J., de Boer, A. & Boezeman, E.H. (2000). The effect of two low-dose propofol infusions on the relationship between six-pulse transcranial electrical stimulation and the evoked lower extremety muscle response. Acta Anaesthesiologica Scandinavica, 44, (pp. 799-803) (5 p.).
van Dongen, E P, ter Beek, H T, Aarts, L P, Schepens, M A, Morshuis, W J, Benning, F J, de Boer, A & Boezeman, E H (2000). The effect of two low-dose propofol infusions on the relationship between six-pulse transcranial electrical stimulation and the evoked lower extremity muscle response. Acta Anaesthesiologica Scandinavica, 44 (7), (pp. 799-803) (5 p.).
Maitland-van der Zee AH, [No Value], de Boer A, [No Value], Leufkens, H G & de Boer, Anthonius (27.12.2000). The interface between pharmacoepidemiology and pharmacogenetics. European Journal of Pharmacology, 410 (2-3), (pp. 121-130) (10 p.).
Van Eijk, Martine E.C., Bahri, Priya, Dekker, Gert, Herings, Ron M C, Porsius, A, Avorn, Jerry & De Boer, Anthonius (01.06.2000). Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects. Journal of Clinical Epidemiology, 53 (6), (pp. 645-651) (7 p.).
  2000 - Professional publications
Mantel-Teeuwisse, A.K., Klungel, O.H., Porsius, A.J. & de Boer, A. (2000). Cholesterolverlagers en doelmatigheid. Pharmaceutisch Weekblad, 135 (4), (pp. 108) (1 p.).
Klungel, O.H., de Boer, A. & Leufkens, H.G.M. (2000). Effectiviteit van geneesmiddelen in de dagelijkse praktijk. Conceptuur, 22, (pp. 10-11) (2 p.).
Maitland-van der Zee, A.H., Klungel, O.H., Leufkens, H.G.M. & de Boer, A. (2000). Geneesmiddeltherapie en het genotype van de patiënt. Pharmaceutisch Weekblad, 135, (pp. 378-379) (2 p.).
Vonk, R., Conemans, J.M.H., Hermens, W.A.J.J., Bernsen, J., Brouwer, M. & de Boer, A. (2000). Is kennis van het cytochroom-genotype CY2D6 en CYP2C19 van belang voor de behandeling van de psychiatrische patient?. Ark, 9 (1), (pp. 14-19) (6 p.).
Klungel, O.H., Paes, A.H.P., Seidell, J.C., Kuijvenhoven, M.M. & de Boer, A. (2000). Sekseverschillen bij de medicamentueze behandeling van hypertensie door de huisarts. Huisarts en Wetenschap, 43 (7), (pp. 303-305) (3 p.).
van de Vijver, D.A.M.C., Roos, R.A.C., Jansen, P.A.F., Porius, A.J. & de Boer, A. (2000). Selective serotonin reuptake inhibitor (SSRI) therapy is associated with an increase in antiparkinsonian drug treatment in patients on levodopa. British Journal of Clinical Pharmacology, 50, (pp. 486-487) (2 p.).
van de Vijver, D.A.M.C., Roos, A.C., Jansen, P.A.F., Porius, A.J. & de Boer, A. (2000). Start of a Selective Serotonin Reuptake Inhibitor (SSRI) and Increase of Antiparkinsonian Drug Treatment in Patients on Levodopa. Pharmacoepidemiology and Drug Safety, 9, (pp. S11-S12) (2 p.).
  1999 - Scholarly publications
Klungel, Olaf H., De Boer, Anthonius, Paes, Arsenio H. P., Herings, Ron M. C., Seidell, Jacob C. & Bakker, Albert (09.01.1999). Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharmacy World and Science, 21 (5), (pp. 217-220) (4 p.).
Klungel, Olaf H., De Boer, Anthonius, Paes, Arsenio H.P., Seidell, Jacob C. & Bakker, Albert (01.10.1999). Cardiovascular diseases and risk factors in a population-based study in The Netherlands: Agreement between questionnaire information and medical records. Netherlands Journal of Medicine, 55 (4), (pp. 177-183) (7 p.).
van Dongen, E.P., ter Beek, H.T, Schepens, M.A., Morshuis, W.J., de Boer, A., Aarts, L.P. & Boezeman, E.H. (1999). Effect of nitrous oxide on myogenic motor potentials evoked by a six pulse train of transcanial electrical stimuli: a possible monitor for aortic surgery. British Journal of Anaesthesia, 82, (pp. 323-328) (6 p.).
van Dongen, E P, ter Beek, H T, Schepens, M A, Morshuis, W J, de Boer, A, Aarts, L P & Boezeman, E H (1999). Effect of nitrous oxide on myogenic motor potentials evoked by a six pulse train of transcranial electrical stimuli - a possible monitor for aortic surgery. British Journal of Anaesthesia, 82 (3), (pp. 323-8) (6 p.).
Klungel, O.H., Stricker, B.H.Ch., Paes, A.H.P., Seidell, J.C., Bakker, A., Voko, Z., Breteler, M.M.B. & de Boer, A. (1999). Excess Stroke Among Hypertensive Men and Women Attributable to Undertreatment of Hypertension. Stroke, 30, (pp. 1312-1318) (7 p.).
Klungel, O.H., Paes, A.H.P., de Boer, A., Kuyvenhoven, M.M., Seidell, J.C. & Bakker, A. (1999). Sex differences in the medication choice for hypertension in general practice. A study written case simulations. Studies on the quality of the pharmacological treatment of hypertension in the general population.
van Dongen, E.P., ter Beek, H.T, Schepens, M.A., Morshuis, W.J., Haas, F.J.L.M., de Boer, A., Boezeman, E.H. & Aarts, L.P. (1999). The relationship between evoked potential and measurements of S-100 protein in cerebrospinal fluid during and after thoracoabdominal aortic aneurysm surgery. Journal of Vascular Surgery, 30, (pp. 293-300) (8 p.).
van Dongen, Eric P, ter Beek, H T, Schepens, M A, Morshuis, W J, Haas, F J, de Boer, A, Boezeman, E H & Aarts, Leon P. (1999). The relationship between evoked potentials and measurements of S-100 protein in cerebrospinal fluid during and after thoracoabdominal aortic aneurysm surgery. Journal of Vascular Surgery, 30 (2), (pp. 293-300) (8 p.).
van Dongen, E P, ter Beek, H T, Schepens, M A, Morshuis, W J, de Boer, A, Aarts, L P & Boezeman, E H (1999). Within patient variability of lower extremity muscle responses to transcranial electrical stimulation with pulse trains in aortic surgery. Clinical Neurophysiology, 110 (6), (pp. 1144-1148) (5 p.).
van Dongen, E P, ter Beek, H T, Schepens, M A, Morshuis, W J, Langemeijer, H J, de Boer, A & Boezeman, E H (1999). Within-patient variability of myogenic motor-evoked potentials to multipulse transcranial electrical stimulation during two levels of partial neuromuscular blockade in aortic surgery. Anesthesia and Analgesia, 88 (1), (pp. 22-27) (6 p.).
Bouvy, Marcel L., Heerdink, Eibert R., Klungel, Olaf H., De Boer, Anthonius, Stuurman-Bieze, Ada G. G. & Leufkens, Hubert G. (09.03.1999). Women with angina pectoris receive less antiplatelet treatment than men. British Journal of General Practice, 49 (441), (pp. 299-300) (2 p.).
Bouvy, M.L., Heerdink, E.R., Klungel, O.H., de Boer, A., Stuurman-Bieze, A.G.G. & Leufkens, H.G.M. (1999). Women with angina pectoris receive less antiplatelet treatment then men. British Journal of General Practice, 49, (pp. 299-300) (2 p.).
  1999 - Professional publications
de Boer, A., Peterse, E.E.M., Mantel-Teeuwisse, A.K. & Porsius, A.J. (1999). De medicamenteuze behandeling van hyperlipidemie. Pharmaceutisch Weekblad, 134 (48), (pp. 1667-1671) (5 p.).
van de Vijver, D.A.M.C. & de Boer, A. (1999). Een omstreden geneesmiddel. Effect van selegiline op mortaliteit in patiënten met de ziekte van Parkinson. Pharmaceutisch Weekblad, 134, (pp. 1602-1603) (2 p.).
van de Vijver, David A M C & De Boer, A. (19.11.1999). Effect van selegeline op mortaliteit bij de ziekte van Parkinson. Pharmaceutisch Weekblad, 134 (46), (pp. 1602-1603) (2 p.).
de Boer, A. (1999). Farmacotherapie en 'evidence-based medicine'. Pharmaceutisch Weekblad, 134 (5), (pp. 167-171) (5 p.).
De Boer, A., Peterse, E.E.M., Teeuwisse, A.K. & Porsius, A.J. (03.12.1999). Farmacotherapie van hyperlipidemie. Pharmaceutisch Weekblad, 134 (48), (pp. 1667-1671) (5 p.).
Mantel-Teeuwisse, A.K., Porsius, A.J. & de Boer, A. (1999). Kwaliteit van behandeling van patiënten met hypercholesterolemie. Pharmaceutisch Weekblad, 134 (48), (pp. 1680-1683) (4 p.).
Klungel, O.H., Seidell, J.C., Paes, A.H.P. & de Boer, A. (1999). Onderbehandeling van hypertensie: voorkomen, gevolgen en determinanten. Cardiologie, 6, (pp. 556-560) (5 p.).
  1998 - Scholarly publications
Klungel, O H, Seidell, J C & de Boer, A (1998). Assessment of control of hypertension in the population. Journal of Hypertension, 16 (3), (pp. 395-6) (2 p.).
ter Riet, G., de Craen, A.J.M., de Boer, Anthonius, Kessels, J. & de Boer, Anthonius (1998). Do Endorphins Mediate Placebo Analgesia? A Critical Commentary on One of the Seminal Papers. Forschende Komplementarmedizin, 5 Suppl S1, (pp. 12-14) (3 p.).
ter Riet, G, de Craen, A J, de Boer, A & Kessels, A G (1998). Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain, 76 (3), (pp. 273-275) (3 p.).
Klungel, O H, Seidell, J C & de Boer, A (1998). Overestimation of the prevalence of hypertension in the population. Journal of Hypertension, 16 (11), (pp. 1702-3) (2 p.).
van Dongen, H P, Leusink, J A, Moll, F L, Brons, F M & de Boer, A (1998). Ruptured abdominal aortic aneurysms - factors influencing postoperative mortality and long-term survival. European Journal of Vascular and Endovascular Surgery, 15 (1), (pp. 62-66) (5 p.).
de Boer, A., Van Dongen, H.P.A., Leusink, J.A. & Moll, F.L. (1998). Ruptured aortic aneurysms [correspondence]. European Journal of Vascular and Endovascular Surgery, 16, (pp. 543-543) (1 p.).
Klungel, O H, de Boer, A, Paes, A H, Seidell, J C & Bakker, Albert (1998). Sex differences in antihypertensive drug use - determinants of the choice of medication for hypertension. Journal of Hypertension, 16 (10), (pp. 1545-1553) (9 p.).
Klungel, O.H., de Boer, A., Paes, A.H.P., Seidell, J.C., Nagelkerke, N.J.D. & Bakker, A. (1998). Undertreatment of hypertension in a population-based study in The Netherlands. Journal of Hypertension, 16, (pp. 1371-1378) (8 p.).
  1998 - Professional publications
Klungel, O.H., de Boer, A., Paes, A.H.P., Seidell, J.C. & Bakker, A. (1998). Aanzienlijke onderbehandeling vrouwen aangetoond. Pharmaceutisch Weekblad, 133, (pp. 872-876) (5 p.).
  1997 - Scholarly publications
Wesselink, R M, de Boer, A, Morshuis, W J & Leusink, J A (1997). Cardio-pulmonary-bypass time has important independent influence on mortality and morbidity. European Journal of Cardio-thoracic Surgery, 11 (6), (pp. 1141-5) (5 p.).
Wesselink, R.M.J., de Boer, A., Morshuis, W.J. & Leusink, J.A. (1997). Cardiopulmonary-bypass time has important independent influence on mortality and morbidity. European Journal of Cardio-thoracic Surgery, 11, (pp. 1141-1145) (5 p.).
Hofsté, W J, Linssen, C A, Boezeman, E H, Hengeveld, J S, Leusink, J A & de-Boer, A (1997). Delirium and cognitive disorders after cardiac operations - relationship to pre- and intraoperative quantitative electroencephalogram. International Journal of Clinical Monitoring and Computing, 14 (1), (pp. 29-36) (8 p.).
Shackleton, D P, Westendorp, R G, Kasteleijn-Nolst Trenité, D G, de Boer, A & Herings, R M (1997). Dispensing epilepsy medication - a method of determining the frequency of symptomatic individuals with seizures. Journal of Clinical Epidemiology, 50 (9), (pp. 1061-8) (8 p.).
Shackleton, D.P., Westendorp, R.G.J., Kasteleijn-Nolst Trenité, T.G.A., de Boer, A. & Herings, R.M.C. (1997). Epileptic medication: a road to determining the number of individuals with seizures. Journal of Clinical Epidemiology, 50, (pp. 1061-1068) (8 p.).
de Boer, A., Oosterwijk, J.C. & Rigters-Aris, C.A.E. (1997). Excessive use of a single donor? And inadvertent consanguinity. Fertility and Sterility, 67, (pp. 1181-1185) (5 p.).
van der Werff, Y D, van der Houwen, H K, Heijmans, P J, Duurkens, V A, Leusink, H A, van Heesewijk, H P & de Boer, A (1997). Postpneumonectomy pulmonary edema - A retrospective analysis of incidence and possible risk factors. Chest, 111 (5), (pp. 1278-1284) (7 p.).
Klungel, O H, de Boer, A, Paes, A H, Seidell, J C & Bakker, Albert (1997). Sex differences in the pharmacological treatment of hypertension - a review of population-based studies. Journal of Hypertension, 15 (6), (pp. 591-600) (10 p.).
Crijns, M.B., Klaver, C., De Boer, A., Van Hees, C., Vermeer, B.J., Vandenbroucke, J. & Bergman, W. (14.05.1997). Ultraviolet exposure and the development of banal and atypical naevi - A cross-sectional study on Curacao and in The Netherlands. Melanoma Research, 7 (5), (pp. 407-416) (10 p.).
Crijns, M.B., Klaver, C.W., de Boer, A., van Hees, C.L.M., Vermeer, B.J., Vandenbroucke, J.P. & Bergman, W (1997). Ultraviolet exposure and the development of banal and atypical naevi - a cross-sectio-nal study on Curaçao and in the Netherlands. Melanoma Research, 7, (pp. 407-416) (10 p.).
Crijns, M B, Klaver, C, de Boer, A, Van Hees, C, Vermeer, B J, Vandenbroucke, J & Bergman, W (1997). Ultraviolet exposure and the development of banal and atypical naevi--a cross-sectional study on Curaçao and in The Netherlands. Melanoma Research, 7 (5), (pp. 407-16) (10 p.).
Lau, H S, de Boer, A, Beuning, K S & Porsius, A (1997). Validation of pharmacy records in drug exposure assessment. Journal of Clinical Epidemiology, 50 (5), (pp. 619-625) (7 p.).
de Boer, A & Porsius, A J (1997). Why do scientists still study and discuss homeopathy?. Pharmacy World and Science, 19 (4), (pp. 176-177) (2 p.).
  1997 - Professional publications
Linssen, C.A.M., Leusink, J.A. & de Boer, A. (1997). Algemeen welbevinden van patiënten na open-hartchirurgie. Nederlands Tijdschrift voor Intensive Care, 12, (pp. 199-203) (5 p.).
de Boer, A. (1997). De waarde van pharmacoeconomics voor beslissingen in de farmacotherapie. In D.D. Breimer, A.W. Broekmans & H.G.M. Leufkens (Eds.), Pharmaco-economics (pp. 11-16) (6 p.).
De Boer, A. (04.04.1997). Epidemiologie van ziekten bij kinderen. Pharmaceutisch Weekblad, 132 (14), (pp. 425-428) (4 p.).
de Boer, A. (1997). Gebruik van prestatieverhogende middelen op sportscholen in Nederland. Pharmaceutisch Weekblad, 132, (pp. 1366-1370) (5 p.).
  1996 - Scholarly publications
Herings, R M, Stricker, B H, de Boer, A, Bakker, Albert, Sturmans, F & Stergachis, A (1996). Current use of thiazide diuretics and prevention of femur fractures. Journal of Clinical Epidemiology, 49 (1), (pp. 115-119) (5 p.).
Lau, H S, Beuning, K S, Postma-Lim, E, Klein-Beernink, L, de Boer, A & Porsius, A J (1996). Non-compliance in elderly people - evaluation of risk factors by longitudinal data analysis. Pharmacy World and Science, 18 (2), (pp. 63-8) (6 p.).
Lau, H.S., Beuning, K.S., Postma-Lin, E., Klein-Beernink, L., de Boer, A. & Porsius, A.J. (1996). Non-compliance in the elderly: evaluation of risk factors by longitudinal data analysis. Pharmacy World and Science, 18, (pp. 63-68) (6 p.).
Tissot van Patot, H A, Leusink, J A, Roodenburg, J, de Jongh, B M, Lau, H S, de Boer, S & de Boer, A (1996). Selective decontamination of the digestive tract - effect of cessation of routine application at an ICU. Pharmacy World and Science, 18 (5), (pp. 171-177) (7 p.).
  1996 - Professional publications
Herings, R.M.C., De Boer, A., Stricker, B.H.Ch., Leufkens, H.G.M. & Porsius, A.J. (24.02.1996). ACE remmers verhogen het risico op hypoglycemie. Nederlands Tijdschrift voor Geneeskunde, 140 (8), (pp. 432-436) (5 p.).
Herings, R.M.C., de Boer, A., Stricker, B.H.Ch., Leufkens, H.G.M. & Porsius, A.J. (1996). ACE-remmers vergroten het risico op hypoglycemie bij diabetici. Nederlands Tijdschrift voor Geneeskunde. Studenteneditie, 140, (pp. 432-436) (5 p.).
Van Dongen, H.P.A., Leusink, J.A., Moll, F.L., Brons, F.M. & de Boer, A. (1996). Behandelingsresultaten bij patiënten met een gebarsten aneurysma van de aorta abdominalis. Nederlands Tijdschrift voor Geneeskunde, 140, (pp. 140-140) (1 p.).
Jonker, D., Dik, E., Willems, M. & de Boer, A. (1996). De behandeling van posttraumatische dystrofie: een literatuur overzicht. Pharmaceutisch Weekblad, 131, (pp. 977-83) (7 p.).
de Boer, A. & Leufkens, H.G.M. (1996). De ontwikkelingsgeneeskundige besparing vanuit de optiek van de farmacoepidemiologie. Innovator, 4, (pp. 16-17) (2 p.).
Lau, H.S., de Boer, A., Klerkx, M.B. & Porsius, A.J. (1996). De volledigheid van de medicatiehistorie in de medische status in het ziekenhuis. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 70-70) (1 p.).
Lau, H.S., de Boer, A., Abas, V. & Porsius, A.J. (1996). Een landelijk onderzoek naar de frequentie van verzoeken om verstrekking van euthanasie middelen in openbare en ziekenhuisapotheken en de afhandeling daarvan. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 15-16) (2 p.).
Shackleton, D.P., Westendorp, R.G.J., Kasteleijn-Nolst Trenité, T.G.A., de Boer, A. & Herings, R.M.C. (1996). Epilepsie medicatie: een methode om het aantal individuen met aanvallen te bepalen. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 45-45) (1 p.).
Leusink, J.A., Van Dongen, H.P.A., Moll, F.L., Brons, F.M. & de Boer, A. (1996). Het gebarsten abdominale aorta-aneurysma: complicaties en mortaliteit bij 309 patiënten. Nederlands Tijdschrift voor Intensive Care, 11, (pp. 131-140) (10 p.).
Leusink, J.A., de Jongh, B.M., Tissot van Patot, H., Rodenburg, J. & de Boer, A. (1996). Infecties bij langdurig beademde patiënten. Nederlands Tijdschrift voor Geneeskunde, 140, (pp. 1054-1054) (1 p.).
Brons, F.M., Dongen, H.M.P., Leusink, J.A. & de Boer, A. (1996). Korte en lange termijn levensverwachting van patienten met een geruptureerd aneurysma aorta abdominalis na hospitalisatie. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 53-53) (1 p.).
Klungel, O.H., de Boer, A., Paes, A.H.P., Seidell, J.C. & Bakker, A. (1996). Man/vrouw verschillen in de behandeling van hypertensie: internationale trends. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 51-51) (1 p.).
Klungel, O.H., de Boer, A., Paes, A.H.P., Seidell, J.C. & Bakker, A. (1996). Onderbehandeling van hypertensie bij mannen en vrouwen: een dwarsdoorsnede populatie-onderzoek in Nederland. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 26-26) (1 p.).
de Boer, A., van Haren, S.F., Hartgens, F., de Boer, D. & Porsius, A.J. (1996). Onderzoek naar het gebruik van prestatie verhogende middelen bij bodybuilders in Nederland. Rotterdam: NeCeDo.
de Boer, A., van Haren, S.F., Hartgens, F., de Boer, D. & Porsius, A.J. (1996). Onderzoek naar het gebruik van prestatieverhogende middelen bij bodybuilders in Nederland. NeCeDo, (pp. 1-55) (55 p.).
van der Houwen, H.K., van der Werf, Y.D., Heijmans, P.J.M., Duurkens, V.A.M., Leusink, J.A., van Heesewijk, H.P.M. & de Boer, A. (1996). Postpneumectomie longoedeem en fresh frozen plasma (FFP) transfusies. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 28-29) (2 p.).
Heymans, F.J.M., van der Werf, Y.D., van Heesewijk, H.P.M., Duurkens, V.A.M., Brutel de la Rivière, A., Leusink, J.A., van der Houwen, H.K. & de Boer, A. (1996). Postpneumectomie-longoedeem; een retrospectief onderzoek naar incidentie en mogelijke risicofactoren. Nederlands Tijdschrift voor Geneeskunde, 140, (pp. 1054-1055) (2 p.).
Herings, R.M.C., de Boer, A., Leufkens, H.G.M. & Urquhart, J. (1996). Selectief voorschrijven van orale anticonceptiva in relatie tot het optreden van veneuze thrombo-embolieën. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 36-37) (2 p.).
Shackleton, D.P., Westendorp, R.G.J., Kasteleijn-Nolst Trenité, T.G.A., de Boer, A. & Vandenbroucke, J.P. (1996). Sterfte in een cohort epilepsie patiënten met een langdurige follow-up. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 40-41) (2 p.).
Herings, R.M.C., Stricker, B.H.Ch. & de Boer, A. (1996). Verhoogd risico op ernstige hypoglycemie na verandering van insuline preparaten. Tijdschrift voor sociale gezondheidszorg : TSG : 14-daags blad van de Algemene Nederlandse Vereniging voor Sociale Gezondheidszorg, 4, (pp. 70-70) (1 p.).
de Boer, A. (1996). Vrouwelijke hormonen en het risico op thrombo-embolische ziekten en kanker. Vrouwelijke hormonen in de dagelijkse praktijk (pp. 35-40) (6 p.). Schering.
de Boer, A. (1996). Why do we still study and discuss homeopathy. EPSA Newsletter, 3, (pp. 6-7) (2 p.).
  1995 - Scholarly publications
Crijns, M B, Klaver, C C, de Boer, A, Van Hees, C L, Vermeer, B J, Vandenbroucke, J P & Bergman, W (1995). A comparative study of atypical and melanocytic naevi on the tropical island Curaçao and in The Netherlands. Melanoma Research, 5 (3), (pp. 161-7) (7 p.).
Herings, R M, de Boer, A, Stricker, B H, Bakker, A. & Sturmans, F (27.01.1995). A rapid method to estimate the incidence rate and prevalence of insulin-dependent diabetes mellitus in children 0-19 years of age. Pharmacy World and Science, 17 (1), (pp. 17-19) (3 p.).
Herings, Ron M. C., Stricker, Bruno H. Ch., De Boer, Anthonius, Bakker, Albert & Sturmans, Ferd (11.09.1995). Benzodiazepines and the risk of falling leading to femur fractures: Dosage more important than elimination half-life. Archives of Internal Medicine, 155 (16), (pp. 1801-1807) (7 p.).
de Boer, A, Oosterwijk, J C & Rigters-Aris, C A (1995). Determination of a maximum number of artificial inseminations by donor children per sperm donor. Fertility and Sterility, 63 (2), (pp. 419-21) (3 p.).
de Boer, A & van Griensven, J M (1995). Drug interactions with thrombolytic agents. Current perspectives. Clinical Pharmacokinetics, 28 (4), (pp. 315-26) (12 p.).
Herings, R M, de Boer, A, Stricker, B H, Leufkens, H G & Porsius, A (1995). Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. The Lancet, 345 (8959), (pp. 1195-8) (4 p.).
  1994 - Scholarly publications
van Hees, C L, de Boer, A, Jager, M J, Bleeker, J C, Kakebeeke, H M, Crijns, M B, Vandenbroucke, J P & Bergman, W (1994). Are atypical nevi a risk factor for uveal melanoma? A case-control study. Journal of Investigative Dermatology, 103 (2), (pp. 202-5) (4 p.).
Ganesh, S, Sier, C F, Griffioen, G, Vloedgraven, H J, de Boer, A, Welvaart, K, van de Velde, C J, van Krieken, J H, Verheijen, J H & Lamers, C B (01.08.1994). Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Research, 54 (15), (pp. 4065-71) (7 p.).
  1993 - Scholarly publications
Kroon, C., De Boer, A., Kroon, J.M., Schoemaker, H.C., Briet, E. & Cohen, A.F. (19.01.1993). Comparison of the bioavailability of heparin and low molecular weight heparin(oids) after subcutaneous administration in healthy volunteers. British Journal of Clinical Pharmacology, 35 (5).
De Boer, A, Kluft, C, Kasper, F J, Kroon, J M, Schoemaker, H C, Breimer, D D, Soons, P A & Cohen, A F (1993). Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects. British Journal of Clinical Pharmacology, 36 (2), (pp. 99-104) (6 p.).
de Boer, A & Herings, R M (1993). Oral contraceptives without prescription. The Lancet, 342 (8877), (pp. 993) (1 p.).
van Schaardenburg, D, Hazes, J M, de Boer, A, Zwinderman, A H, Meijers, K A & Breedveld, F C (1993). Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. Journal of Rheumatology, 20 (1), (pp. 45-52) (8 p.).
de Boer, A, Kluft, C, Gerloff, J, Dooijewaard, G, Günzler, W A, Beier, H, van der Meer, F J & Cohen, A F (02.08.1993). Pharmacokinetics of saruplase, a recombinant unglycosylated human single-chain urokinase-type plasminogen activator and its effects on fibrinolytic and haemostatic parameters in healthy male subjects. Thrombosis and Haemostasis, 70 (2), (pp. 320-5) (6 p.).
Bavinck, J N, De Boer, A, Vermeer, B J, Hartevelt, M M, van der Woude, F J, Claas, F H, Wolterbeek, R & Vandenbroucke, J P (1993). Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. British Journal of Dermatology, 129 (3), (pp. 242-9) (8 p.).
Lansink, M, de Boer, A, Dijkmans, B A, Vandenbroucke, J P & Hazes, J M (01.03.1993). The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clinical and Experimental Rheumatology, 11 (2), (pp. 171-174) (4 p.).
  1993 - Professional publications
Van Der Kuy, P.H.M., Meulendijk, A.J.M., Kraaijenga, J.J. & De Boer, A. (21.12.1993). Meta-analyse van de effectiviteit van celiprolol bij astma. Pharmaceutisch Weekblad, 128 (44), (pp. 1293-1297) (5 p.).
  1992 - Scholarly publications
Cohen, A F, Burggraaf, K, de Boer, A & Kluft, C (04.12.1992). Clearance of plasminogen activator--a major determinant of plasma concentration - therapeutic and diagnostic implications. Annals of the New York Academy of Sciences, 667, (pp. 443-9) (7 p.).
Cohen, A.F., Burggraaf, K., De Boer, A. & Kluft, C. (21.03.1992). Clearance of plasminogen activators - a major determinant of plasma concentration: Therapeutic and diagnostic implications. Annals of the New York Academy of Sciences, 667, (pp. 443-449) (7 p.).
Krulder, J W, de Boer, A, van den Besselaar, A M, Cohen, A F, Schoemaker, H C, Briët, E & Meinders, A E (06.07.1992). Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers. Thrombosis and Haemostasis, 68 (1), (pp. 30-2) (3 p.).
Kroon, C, ten Hove, W R, de Boer, A, Kroon, J M, van der Pol, J M, Harthoorn-Lasthuizen, E J, Schoemaker, H C, van der Meer, F J & Cohen, A F (1992). Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers. Circulation, 86 (5), (pp. 1370-5) (6 p.).
de Boer, A, Kluft, C, Dooijewaard, G, Kasper, F J, Kroon, J M, Breimer, D D, Stiekema, J C & Cohen, A F (10.11.1992). Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise. Thrombosis and Haemostasis, 68 (5), (pp. 550-5) (6 p.).
de Boer, A, Kluft, C, Kroon, J M, Kasper, F J, Schoemaker, H C, Pruis, J, Breimer, D D, Soons, P A, Emeis, J J & Cohen, A F (23.01.1992). Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator. Thrombosis and Haemostasis, 67 (1), (pp. 83-87) (5 p.).
Danhof, M, de Boer, A, Magnani, H N & Stiekema, J C (1992). Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis, 22 (2), (pp. 73-84) (12 p.).
de Boer, A, Kroon, J M, Kroon, C, van Vliet, A, Schoemaker, H C, Breimer, D D, Donoghue, S & Cohen, A F (06.07.1992). Pronounced effects of the combination of a new thromboxane antagonist (GR32191) and heparin on bleeding time in man. Thrombosis and Haemostasis, 68 (1), (pp. 24-9) (6 p.).
  1991 - Scholarly publications
Soons, P A, De Boer, A, Cohen, A F & Breimer, D D (1991). Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green. British Journal of Clinical Pharmacology, 32 (6), (pp. 697-704) (8 p.).
de Boer, A, Stiekema, J C, Danhof, M & Breimer, D D (1991). Influence of chlorthalidone on the pharmacokinetics and pharmacodynamics of Org 10172 (Lomoparan), a low molecular weight heparinoid, in healthy volunteers. Journal of Clinical Pharmacology, 31 (7), (pp. 611-7) (7 p.).
Kroon, C, de Boer, A, Kroon, J M, Schoemaker, H C, van den Meer, F J, Cohen, A F & Schoenmaker, H C (20.04.1991). Influence of skinfold thickness on heparin absorption. The Lancet, 337 (8747), (pp. 945-6) (2 p.).
de Boer, A, Stiekema, J C, Danhof, M, Moolenaar, A J & Breimer, D D (1991). Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers. European Journal of Clinical Pharmacology, 41 (3), (pp. 245-50) (6 p.).
de Boer, A, Danhof, M, Cohen, A F, Magnani, H N & Breimer, D D (01.08.1991). Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers. Thrombosis and Haemostasis, 66 (2), (pp. 202-7) (6 p.).
Dooijewaard, G, de Boer, A, Turion, P N, Cohen, A F, Breimer, D D & Kluft, C (23.01.1991). Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma. Thrombosis and Haemostasis, 65 (1), (pp. 82-6) (5 p.).
de Boer, A, Stiekema, J C, Danhof, M, van Dinther, T G, Boeijinga, J K, Cohen, A F & Breimer, D D (1991). Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers. Antimicrobial Agents and Chemotherapy, 35 (10), (pp. 2110-2115) (6 p.).
De Boer, A, Stiekema, J C, Danhof, M & Breimer, D D (1991). The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172. British Journal of Clinical Pharmacology, 32 (1), (pp. 23-9) (7 p.).
  1990 - Scholarly publications
Kroon, C, de Boer, A, Hoogkamer, J F, Schoemaker, H C, van der Meer, E J, Edelbroek, P M & Cohen, A F (1990). Detection of drug interactions with single dose acenocoumarol - new screening method?. International Journal of Clinical Pharmacology Therapy and Toxicology, 28 (8), (pp. 355-360) (6 p.).
Stiekema, J C, de Boer, A, Danhof, M, Kroon, C, Broekmans, A W, van Dinther, T G, Voerman, J & Breimer, D D (1990). Interaction of the combined medication with the new low-molecular-weight heparinoid Lomoparan (Org 10172) and acenocoumarol. Haemostasis, 20 (3), (pp. 136-46) (11 p.).
^ top
Gegenereerd op 2017-10-18 06:05:09

His research interests  are directed on methods of pharmacoepidemiology, pharmacogenetics in the field of cardiovascular diseases. Large prescription databases linked to medical information are used for these purposes.  Presently he is the first promotor of 11 PhD students and second promotor of 1 PhD student. The number of peer reviewed, both international and national, papers is appr. 475. His H-factor is 50 (Web of Sciences)

Gegenereerd op 2017-10-18 06:05:09

He has obtained the basic teaching qualification (BKO) of Utrecht University. He is involved in several courses of the Bachelor of Pharmacy, College of Pharmaceutical Sciences, Master of Pharmacy and the Research Master Drug Innovation. He has followed the Center of Excellence of Univeristy Teaching (CEUT). He is responsible for several postacademic trainings especially for community and hospital pharmacists (methods of drug research, cardiovascular topics, diabetes mellitus, pharmacotherapy).

Gegenereerd op 2017-10-18 06:05:09
Additional functions and activities

 

  • Chairman of the Dutch Medicines Evaluation Board (0,6 fte)
  • Chairman of the Board of the National Institute of Post-Academic Education of Pharmacy
  • Chairman of the Certification Committee of the Dutch Society of Clinical Pharmacology and Biopharmacy
  • Chairman of the Board of Asian Eye Care (www.asianeyecare.nl)
  • Chairman of the Wefers Bettink Foundation
  • Vice-chairman of the Programme Good Use of Drugs (´Goed Gebruik Geneesmiddelen´) of ZonMw.
  • European Senior Editor of the British Journal of Clinical Pharmacology 
  • Member of the Editorial Board of the Journal of Research in Pharmacy Practice
  • Member Reflection Team Reporting Center Animal Experiments UU
Gegenereerd op 2017-10-18 06:05:09
Full name
prof. dr. A. de Boer Contact details
David de Wiedgebouw

Universiteitsweg 99
Room 3.78
3584 CG  UTRECHT
The Netherlands


Phone number (direct) +31 62 027 9938
Phone number (department) +31 30 253 7324
Mobile phone +31 62 027 9938
Postal address
Universiteitsweg 99
3584 CG    UTRECHT
The Netherlands
Availability
Mo Tue Wed Thu Fr
Morning
Afternoon
Gegenereerd op 2017-10-18 06:05:09
Last updated 10.09.2017